{"study_id": 52688, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of chondroitin sulfate proteoglycan degradation in improving nerve regeneration outcomes in animal models.", "results_summary": "Enzymatic degradation of inhibitory chondroitin sulfate proteoglycan mimics endogenous processes that enhance nerve regeneration, improving outcomes in direct nerve repair and grafting in animal models. The study highlights the balance between growth-promoting and growth-inhibiting factors in nerve regeneration.", "population_specificity": "Animal models (not specified further).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:01.203435+00:00"}
{"study_id": 185253, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the pharmacokinetics of chitosan-derived glucosamine and biofermentation-derived glucosamine as nutritional supplementation.", "results_summary": "The study examined the plasma concentration-time curve of glucosamine after oral administration but did not report specific findings related to chondroitin's effects.", "population_specificity": "Healthy men and women.", "effective_dosage": "1500 mg of glucosamine sulfate 2KCl (single dose).", "study_duration": "Single dose with blood sampling up to 8 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:01.521612+00:00"}
{"study_id": 185254, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to assess the quality and biological activity of chondroitin sulfate and glucosamine in food supplements compared to pharmaceuticals.", "results_summary": "Most samples had lower chondroitin sulfate and glucosamine content than declared, with contamination and mixed molecular weight species. Only 1 out of 5 biologically screened samples showed effective in vitro action comparable to pharmaceuticals.", "population_specificity": "In vitro human synoviocyte and chondrocyte primary cell models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:04.232200+00:00"}
{"study_id": 185256, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of glucosamine (and indirectly chondroitin, as a combined component) in alleviating knee osteoarthritis symptoms and preserving joint function.", "results_summary": "The study found a marginally favorable effect of glucosamine on pain relief (VAS scores) but a small, non-significant effect on knee function (WOMAC). The JKOM meta-analysis suggested glucosamine's superiority over placebo in symptom alleviation, though sample sizes were small.", "population_specificity": "Elderly individuals with knee osteoarthritis.", "effective_dosage": "Not specified for chondroitin.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:05.267545+00:00"}
{"study_id": 185255, "supplement_id": 1021, "safety_score": "87", "efficacy_score": 65, "quality_score": 72, "study_goal": "The researchers aimed to examine the prevalence and patterns of natural product dietary supplement (NDS) use, including Chondroitin, among rheumatoid arthritis (RA) patients for self-management.", "results_summary": "Chondroitin was among the most commonly reported NDS used by RA patients worldwide, with 47% of patients finding NDS effective overall, though efficacy for Chondroitin specifically was not detailed. Adverse side effects were reported by 13% of NDS users, but Chondroitin-specific safety data was not isolated.", "population_specificity": "Rheumatoid arthritis patients across 11 countries.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Used concomitantly with RA pharmaceuticals in a majority of cases.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:05.605564+00:00"}
{"study_id": 185257, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy and tolerability of glucosamine hydrochloride plus chondroitin sulfate (GC) against undenatured type II collagen (UC-II) and placebo for managing knee osteoarthritis symptoms.", "results_summary": "The study found that GC was less effective than UC-II in reducing overall WOMAC scores and its subscales (pain, stiffness, physical function) but did not differ in safety outcomes. No significant adverse effects were reported for GC.", "population_specificity": "191 volunteers with knee osteoarthritis.", "effective_dosage": "1200 mg chondroitin sulfate daily (combined with 1500 mg glucosamine hydrochloride).", "study_duration": "180 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:05.788020+00:00"}
{"study_id": 185259, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine whether glucosamine and chondroitin supplementation reduces systemic inflammation and modulates other pathways in healthy, overweight adults.", "results_summary": "The study found a 23% reduction in serum CRP concentrations after chondroitin and glucosamine supplementation compared to placebo, with no significant differences in other biomarkers. Proteomics analysis indicated a significant reduction in the \"cytokine activity\" pathway.", "population_specificity": "Healthy, overweight adults (BMI 25.0-32.5 kg/m\u00b2), aged 20-55 years (9 men, 9 women).", "effective_dosage": "1200 mg/d chondroitin sulfate combined with 1500 mg/d glucosamine hydrochloride.", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:06.697276+00:00"}
{"study_id": 185258, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of 24-week oral N-acetyl glucosamine and chondroitin sulfate supplementation on knee pain, self-reported knee function, physical activity, and physical performance in middle-aged and older Japanese adults with knee pain and/or stiffness.", "results_summary": "The study found that chondroitin sulfate supplementation significantly improved self-reported knee function (JKOM score) and household physical activity after 12 weeks, but did not significantly affect knee pain (VAS) or physical performance tests.", "population_specificity": "Middle-aged and older Japanese adults (52-87 years) with knee pain and/or stiffness (11 men and 39 women).", "effective_dosage": "180 mg chondroitin sulfate daily (combined with 100 mg N-acetyl glucosamine).", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:07.113990+00:00"}
{"study_id": 185261, "supplement_id": 1021, "safety_score": "60", "efficacy_score": null, "quality_score": 40, "study_goal": "The researchers aimed to investigate potential hepatotoxicity associated with Move Free Advanced, a supplement containing chondroitin, glucosamine, and other ingredients.", "results_summary": "The study reported two cases of hepatotoxicity linked to Move Free Advanced, resolving after discontinuation. Chinese skullcap was identified as the likely cause, not chondroitin.", "population_specificity": "Two patients who developed hepatotoxicity after taking Move Free Advanced.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:09.104539+00:00"}
{"study_id": 185260, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to determine how chondroitin sulfate affects the colonization and activity of Desulfovibrio piger and its impact on gut microbiota and hydrogen sulfide (H2S) levels.", "results_summary": "Chondroitin sulfate increased D. piger and H2S levels without compromising gut barrier integrity and altered the microbiota's substrate utilization preferences, enabling consumption of more reduced carbon sources and increasing Collinsella aerofaciens abundance.", "population_specificity": "Gnotobiotic mice colonized with human gut bacterial species, including D. piger.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:09.798263+00:00"}
{"study_id": 6950, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to determine whether hydrochar could generate reactive oxygen species (ROS) in dark and anaerobic conditions and assess its effectiveness in reducing Cr(VI) to Cr(III).", "results_summary": "The study found that hydrochar combined with bicarbonate generated superoxide radicals (O2\u2022-) under alkaline conditions, reducing over 95% of Cr(VI) to Cr(III). The mechanism involved electron transfer and oxygen activation within hydrochar's oxygenated functional groups.", "population_specificity": "Not specified (laboratory study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:13.259190+00:00"}
{"study_id": 6951, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 92, "quality_score": 85, "study_goal": "The researchers aimed to determine the effectiveness of activated carbon derived from cabbage waste in removing hexavalent chromium (Cr (VI)) from synthetic and tannery wastewater.", "results_summary": "The study found that the activated carbon achieved 99.87% chromium removal from synthetic wastewater and 83.81% from tannery wastewater under optimized conditions, with the adsorption process being spontaneous, exothermic, and following pseudo-second-order kinetics.", "population_specificity": "Synthetic and tannery wastewater samples.", "effective_dosage": "Adsorbent dose of 2 g/L for synthetic wastewater.", "study_duration": "Contact time of 150 minutes.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:14.146439+00:00"}
{"study_id": 6949, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the wear on opposing enamel caused by different manufacturing techniques for cobalt-chromium (Co-Cr) and nickel-chromium (Ni-Cr) alloys used in dental prostheses.", "results_summary": "The study found that selective laser melting (SLM) techniques for Co-Cr alloys resulted in comparable enamel wear to conventional casting methods, while Ni-Cr alloys caused lower enamel wear. Heat treatment improved the hardness of SLM-fabricated Co-Cr alloys without increasing enamel wear.", "population_specificity": "Human enamel cusps (in vitro study)", "effective_dosage": "Not applicable (material testing, not supplementation)", "study_duration": "Testing conducted over 240,000 chewing cycles", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:14.915434+00:00"}
{"study_id": 6952, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of chromium supplementation on cardiovascular-metabolic risk factors, including lipid profile, glycemic index, anthropometric factors, blood pressure, and liver function.", "results_summary": "Chromium supplementation significantly reduced fasting blood glucose, A1C, HOMO-IR, and insulin levels, with slight improvements in lipid profiles and anthropometric measures. However, it slightly increased HDL, ALT, systolic blood pressure, and diastolic blood pressure, while having no significant effect on AST.", "population_specificity": "Not specified (participant count ranged from 1 to 137 across 20 trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:15.750728+00:00"}
{"study_id": 6953, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how chromium, alone or combined with formoterol, improves quality of life in obese individuals with lung anomalies by addressing metabolic and inflammatory components.", "results_summary": "Chromium treatment (alone or combined) significantly reduced body weight, improved lipid profiles (lower LDL/triglycerides, increased HDL), normalized lung tissue, and reduced inflammatory markers (IL-1\u03b2, IL-17\u03b1). The combination therapy (OACRF) showed superior outcomes in asthma control and metabolic improvements.", "population_specificity": "Obese male Wistar rats with induced asthma.", "effective_dosage": "400 \u03bcg/kg chromium (frequency not specified).", "study_duration": "5 days (aligned with asthma induction protocols).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:16.437435+00:00"}
{"study_id": 6955, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of mesoporous-hydrochar derived from Acacia falcata leaves for adsorbing and reducing Cr(VI) in water treatment applications.", "results_summary": "The adsorbent demonstrated a high Cr(VI) adsorption capacity (30.47 mg/g), with kinetic and equilibrium studies supporting a heterogeneous adsorption mechanism. It maintained over 95% removal efficiency in real-world water matrices but showed reduced performance after four regeneration cycles.", "population_specificity": "Not applicable (in vitro study using water matrices).", "effective_dosage": "Not applicable (batch experiments with adsorbent material).", "study_duration": "Not specified (batch experiments without explicit duration).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:18.153367+00:00"}
{"study_id": 6956, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to develop and evaluate polyethylenimine-functionalized lignin/cellulose beads (PLCBs) as biosorbents for removing hexavalent chromium (Cr(VI)) from aqueous solutions and assess their adsorption performance and catalytic detoxification potential.", "results_summary": "The study found that PLCBs exhibited exceptional Cr(VI) adsorption capacity (326.80 mg\u00b7g-1), driven by electrostatic attraction, chemical reduction, and chelation, while also converting toxic Cr(VI) into less toxic Cr(III). The beads demonstrated excellent stability, recyclability, and maintained adsorption efficiency over multiple cycles.", "population_specificity": "Industrial wastewater (aqueous solutions)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:19.430910+00:00"}
{"study_id": 6959, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the mechanisms of Cr(VI) bioremediation by microbial enzymatic reduction and its effects on anaerobic digestion processes.", "results_summary": "Cr(VI) exposure >5 mg/L inhibited anaerobic digestion and reduced Cr(VI) removal efficiency. Enzymatic reduction dominated Cr(VI) transformation (81.6%-89.3%), with extracellular enzymes playing a significant role.", "population_specificity": "Microbial anaerobic digestion systems (not human or animal).", "effective_dosage": ">5 mg/L Cr(VI) concentration.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:22.787691+00:00"}
{"study_id": 6957, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of nano zero-valent iron/nickel (nZVI/Ni) in remediating chromium (VI)-contaminated soil under acid rain conditions.", "results_summary": "The study found that nZVI/Ni effectively reduced Cr(VI) to Cr(III) in contaminated soil, with optimal fixation efficiency at a dosage of 0.10% (w/w) and pH 4.5. The remediated soil showed decreased acid-extractable and reduced chromium (30% to 9%) and increased oxidizable and residual chromium (70% to 91%), with leached Cr concentrations below safety standards.", "population_specificity": "Chromium-contaminated soil under simulated acid rain conditions.", "effective_dosage": "0.10% (w/w) nZVI/Ni.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:23.265510+00:00"}
{"study_id": 6960, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how the combination of arbuscular mycorrhizal fungi (AMF) and biochar influences bacterial networks and soil quality during chromium (Cr) remediation in Ricinus communis plants.", "results_summary": "The AMF-biochar combination significantly increased castor plant fresh weight (359.70%) and soil quality index (121.25%) under Cr stress, while altering bacterial community composition and enhancing network complexity.", "population_specificity": "Ricinus communis (castor) plants under chromium stress (150 mg/kg Cr).", "effective_dosage": "150 mg/kg Cr stress applied in pot experiments.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:23.928269+00:00"}
{"study_id": 6961, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of polyacrylonitrile/polyethylenimine porous microspheres (PAN/PEI PM) in removing hexavalent chromium (Cr(VI)) from wastewater.", "results_summary": "The PAN/PEI PM demonstrated high Cr(VI) adsorption efficiency (up to 194.5 mg/g) and maintained over 64% removal efficiency after five cycles. The adsorption process was primarily driven by complexation, electrostatic interactions, and redox reduction of Cr(VI) to Cr(III).", "population_specificity": "Not applicable (in vitro study on wastewater treatment).", "effective_dosage": "Not applicable (adsorption capacity measured in mg/g).", "study_duration": "Not specified (adsorption cycles tested).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:25.348121+00:00"}
{"study_id": 6962, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 95, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of a CN-Z8C heterojunction photocatalyst in reducing and removing toxic Cr (VI) from water.", "results_summary": "The CNZ8C heterojunction demonstrated nearly 100% removal efficiency for Cr (VI), with improved charge separation and adsorption, and maintained effectiveness over 5 reuse cycles. Mechanistic studies confirmed the reduction of Cr (VI) to the less toxic +3 state.", "population_specificity": "Not applicable (in vitro study on water remediation).", "effective_dosage": "Not applicable (material ratio: CNZ8C 5:5).", "study_duration": "Not specified (reusability tested over 5 cycles).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:25.890566+00:00"}
{"study_id": 6964, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether heteroatom doping (specifically cobalt and copper) could enhance the Cr(VI) removal efficacy of greigite from contaminated water.", "results_summary": "Cobalt doping significantly improved greigite's ability to adsorb and reduce Cr(VI) by altering electron occupancy and increasing electron transfer rates, while copper doping had the opposite effect. The magnetic properties of greigite remained intact, allowing easy recovery from water.", "population_specificity": "Not applicable (in vitro study on material properties)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:27.889946+00:00"}
{"study_id": 6963, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the simultaneous removal mechanisms and mutual interactions of chromium (Cr(VI)) with phosphorus and antimony in textile dye wastewater using electrocoagulation.", "results_summary": "The study found that Cr(VI) was effectively removed (89.97%) through internal adsorption co-precipitation by Fe(OH)\u2083, though its removal was inhibited by the presence of phosphorus. Cr(VI) also accelerated Fe(OH)\u2083 floc agglomeration, improving phosphorus removal efficiency.", "population_specificity": "Textile dye wastewater (not human or animal subjects).", "effective_dosage": "Not applicable (study focused on wastewater treatment parameters).", "study_duration": "20 minutes (reaction time under optimal conditions).", "interactions": "Competition with phosphorus reduced Cr(VI) removal efficiency.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:27.936279+00:00"}
{"study_id": 6966, "supplement_id": 1022, "safety_score": "20", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to review recent advances in the treatment of toxic heavy metals, including chromium, focusing on clinical features, prognosis, and treatment options.", "results_summary": "The abstract highlights chromium as a toxic heavy metal with systemic and organ complications, noting that chelating agents like DMSA and DMPS are used for treatment, but no specific antidote for chromium is mentioned. Newer treatments with antioxidant and anti-inflammatory properties show promise but require further clinical trials.", "population_specificity": "General human exposure, particularly in developing countries.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:31.400576+00:00"}
{"study_id": 6967, "supplement_id": 1022, "safety_score": "20", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether dopamine could mitigate chromium (Cr) stress in tomato plants and explore the underlying molecular mechanisms.", "results_summary": "Dopamine application reduced oxidative stress and Cr accumulation in tomato plants by enhancing antioxidant enzyme activity and upregulating stress-related genes. H2O2 signaling was identified as a key factor in dopamine-induced Cr tolerance.", "population_specificity": "Tomato plants (Solanum lycopersicum)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:31.898227+00:00"}
{"study_id": 6965, "supplement_id": 1022, "safety_score": "10", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the individual and combined effects of gibberellic acid (GA3) and biofertilizer (Agrobacterium fabrum) in alleviating chromium toxicity in wheat.", "results_summary": "The study found that the combined application of GA3 and A. fabrum significantly improved plant growth metrics (e.g., shoot and root weight, length) under chromium stress compared to control conditions. The treatment was effective in mitigating chromium toxicity in wheat.", "population_specificity": "Wheat plants exposed to chromium-contaminated soil.", "effective_dosage": "300 mg Cr/kg soil, 600 mg Cr/kg soil, GA3 (5 mg/L solution), and A. fabrum biofertilizer.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:32.085833+00:00"}
{"study_id": 6969, "supplement_id": 1022, "safety_score": "10", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of chronic low-dose hexavalent chromium (Cr (VI)) exposure on brain and kidney tissues in Swiss albino mice, focusing on oxidative stress, histoarchitectural changes, gene expression, and epigenetic modifications.", "results_summary": "Chronic Cr (VI) exposure significantly elevated oxidative stress markers, caused DNA fragmentation, reduced organo-somatic index, altered histoarchitecture, and upregulated apoptotic gene expression. Epigenetic modifications via DNA hypermethylation were also observed, impacting DNA repair and epigenetic regulatory genes.", "population_specificity": "Swiss albino mice", "effective_dosage": "2, 5, and 10 ppm via drinking water", "study_duration": "4 and 8 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:35.015820+00:00"}
{"study_id": 6968, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to develop and evaluate novel cellulose-based photocatalytic hydrogel materials (CF and CFS) for the efficient degradation of Cr(VI) in aquatic environments.", "results_summary": "The study found that CFS, a hydrogel material cross-linked with Fe(III) and sodium citrate, achieved 100% degradation of Cr(VI) within 90 minutes under optimal conditions, exhibited superior visible-light absorption, and maintained stability and reusability over five cycles.", "population_specificity": "Aquatic environments contaminated with Cr(VI).", "effective_dosage": "150 mg/L Cr(VI) degraded under 0.3 M Fe(III) with a Fe(III):SC molar ratio of 2:1.", "study_duration": "90 minutes for degradation; stability tested over five cycles.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:35.569028+00:00"}
{"study_id": 6970, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a stable, long-term solution for immobilizing Cr(VI) pollution by forming chromite under ambient conditions and optimizing its precipitation using microbial methods.", "results_summary": "The study found that chromite formation occurs at pH above 7 and Fe(III)/Cr(III) ratios exceeding 1, with Fe(III) occupying tetrahedral sites for stability. Chromite remained stable for over 180 days, and the method offers potential for magnetic separation recovery.", "population_specificity": "Cr-contaminated water and soil sites.", "effective_dosage": "Not specified", "study_duration": "Over 180 days (long-term stability tests)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:36.433534+00:00"}
{"study_id": 6971, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of a porous cellulose nanofiber aerogel modified with graphene oxide for adsorbing Cr(VI) from industrial wastewater.", "results_summary": "The study found that CNF60/GO2 was the most effective aerogel adsorbent for Cr(VI), achieving an adsorption capacity of 13.48 mg/g at 100 ppm concentration within 30 minutes. The aerogels exhibited high porosity (96-98%) and low shrinkage (<7%), enhancing their adsorption properties.", "population_specificity": "Industrial wastewater (textile industry waste).", "effective_dosage": "100 ppm concentration of Cr(VI).", "study_duration": "30 minutes (adsorption time).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:36.917872+00:00"}
{"study_id": 6954, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize current limitations, gaps, and state-of-the-art technologies for chromium (Cr) removal in industrial wastewater systems over the past 10 years.", "results_summary": "The review found that conventional physicochemical techniques are often insufficient for Cr removal, with limited research conducted at an industrial scale. Advanced integrated systems show promise but require further development for effective large-scale application.", "population_specificity": "Industrial wastewater systems (tannery, electroplating, textile, mining, steel mills, pigments, wood processing).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:37.214022+00:00"}
{"study_id": 6972, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop a novel composite material (SCG) for efficient removal and reduction of toxic Cr(VI) in wastewater.", "results_summary": "The SCG composite material successfully removed 94.7% of Cr(VI) at pH 4, with a 67.5% reduction rate, and maintained effectiveness (84% removal) at pH 7. The material demonstrated good pH adaptability and practical applicability.", "population_specificity": "Not applicable (in vitro study on wastewater treatment).", "effective_dosage": "1 g/L of SCG material.", "study_duration": "150 minutes.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:39.780656+00:00"}
{"study_id": 6973, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether chromium yeast (CY) supplementation increases milk protein in heat-stressed dairy cows by promoting microbial crude protein (MCP) synthesis through regulation of rumen microorganisms and amino acid metabolites.", "results_summary": "CY supplementation increased ruminal MCP concentration and altered the relative abundances of specific rumen bacteria, while reducing certain amino acid concentrations. These changes correlated with higher milk protein content and yield in heat-stressed dairy cows.", "population_specificity": "Mid-lactation dairy cows under heat stress", "effective_dosage": "0.36 mg Cr/kg DM", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:40.327105+00:00"}
{"study_id": 6974, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 82, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of a glutaraldehyde-cross-linked chitosan and natural zeolite composite film (GA-CS-ZEO) for removing hexavalent chromium (Cr(VI)) from aqueous solutions.", "results_summary": "The composite film achieved a maximum Cr(VI) removal efficiency of 82.39% under optimized conditions (50 mg L-1 Cr(VI), pH 2.0, 100 min contact time, 20 \u00b0C). The removal process was spontaneous, endothermic, and primarily driven by physical mechanisms like electrostatic interactions and hydrogen bonding.", "population_specificity": "Aqueous solutions (in vitro study)", "effective_dosage": "50 mg L-1 Cr(VI) concentration", "study_duration": "100 minutes (contact time)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:41.722653+00:00"}
{"study_id": 6977, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the anti-inflammatory and antioxidant potential of Chromium-D-phenylalanine (Cr(D-Phe)\u2083 using in vivo and in silico approaches.", "results_summary": "Cr(D-Phe)\u2083 demonstrated significant anti-inflammatory activity (34.40% oedema inhibition) and antioxidant effects (increased GSH, reduced LPO and TNF-\u03b1), with molecular docking suggesting strong binding affinity to COX enzymes.", "population_specificity": "Rats (carrageenan-induced paw oedema model)", "effective_dosage": "40 \u03bcg/kg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:44.639515+00:00"}
{"study_id": 6976, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of chromium hydroxide-impregnated ethanolamine-modified polystyrene (Cr@EA-PS) as a sorbent for removing cadmium (Cd(ii)) ions from wastewater.", "results_summary": "The study found that Cr@EA-PS exhibited the highest adsorption capacity (13.6 mg g-1) for Cd(ii) ions, nearly 10-fold higher than unmodified polystyrene, due to enhanced surface properties and porosity. The adsorption mechanism involved chemisorption and physical adsorption, with the process following a pseudo-second-order model.", "population_specificity": "Wastewater from paint and pigment industries (in vitro study, no human or animal subjects).", "effective_dosage": "Not specified (adsorption capacity measured in mg g-1).", "study_duration": "Not specified (laboratory-based adsorption study).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:45.711721+00:00"}
{"study_id": 6978, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the adsorption efficiency of a nitrogen-doped activated carbon (AC5-600) for removing hexavalent chromium (Cr6+) ions from contaminated solutions.", "results_summary": "The study found that AC5-600 effectively adsorbed Cr6+ ions, with a maximum sorption capacity of 318 mg.g-1, and the process was best described by the Elovich and pseudo-second-order models. The adsorption was influenced by pH, with optimal removal at pH 1.5 due to electrostatic interactions.", "population_specificity": "Not applicable (in vitro study using synthetic solutions).", "effective_dosage": "Not applicable (adsorption capacity measured in mg.g-1).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:45.910393+00:00"}
{"study_id": 6975, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of Azolla pinnata in phytoremediating chromium (Cr VI)-contaminated water and its potential to mitigate chromium stress in plants.", "results_summary": "Azolla pinnata effectively removed Cr (VI) from water, with phytoremediation capacity ranging from 70% at low concentrations (0.1 ppm) to 19.53% at high concentrations (90 ppm). Treatment with Azolla reduced chromium accumulation in Vicia faba plants, improved growth metrics, and mitigated chromosomal aberrations and DNA degradation.", "population_specificity": "Vicia faba plants (in vivo) and Azolla pinnata (in vitro).", "effective_dosage": "Cr concentrations ranged from 0.05 to 90 ppm; Azolla was used at a ratio of 25:1 (volume mL: fresh weight g).", "study_duration": "2 days for in vitro phytoremediation; duration for in vivo pot experiments not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:46.443239+00:00"}
{"study_id": 6979, "supplement_id": 1022, "safety_score": "30", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the dose-response effects of polyphenon-60 derived from green tea (P60-GT) on hexavalent chromium [Cr(VI)]-induced genotoxic damage and apoptosis.", "results_summary": "Cr(VI) significantly increased genotoxic damage and reduced cell viability, while pre-treatment with P60-GT reduced this damage by up to 74%, with the 30\u2009mg/kg dose showing the highest efficacy. However, the 45\u2009mg/kg dose resulted in 100% lethality due to synergistic toxicity with Cr(VI).", "population_specificity": "Male Hsd:ICR mice", "effective_dosage": "P60-GT (15, 30, or 45\u2009mg/kg gavage); Cr(VI) (20\u2009mg/kg of CrO3 intraperitoneally)", "study_duration": "Peripheral blood samples were collected at 24, 48, and 72\u2009hr", "interactions": "Synergistic toxicity noted between P60-GT (45\u2009mg/kg) and Cr(VI)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:48.454091+00:00"}
{"study_id": 6980, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how pyrolysis temperatures and chlorinated additives (PVC and FeCl3) influence the stabilization, leachability, and ecological risks of chromium (Cr) in biochar derived from municipal sewage sludge.", "results_summary": "FeCl3 treatments reduced Cr concentrations by up to 72.5% and promoted its transformation into oxidizable fractions, enhancing stability. However, FeCl3 treatments exhibited elevated ecological risk levels, reaching moderate to considerable risk categories at higher concentrations and temperatures.", "population_specificity": "Municipal sewage sludge (SS) treated via co-pyrolysis.", "effective_dosage": "10% and 20% concentrations of PVC and FeCl3.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:48.653467+00:00"}
{"study_id": 6981, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of chromium (Cr) supplementation, alone and in combination with palmitic acid (C16:0), on production responses in early-lactation cows.", "results_summary": "Cr supplementation increased yields of milk, milk protein, and milk lactose during the treatment period and had carryover effects, improving milk production even after cessation. It also interacted with time to influence plasma insulin, nonesterified fatty acids, and BHB levels.", "population_specificity": "Multiparous Holstein cows in early lactation (1-56 days in milk).", "effective_dosage": "0.45 mg Cr/kg of diet DM, administered through the vitamin and mineral mix.", "study_duration": "24 days (fresh period) with a 31-day carryover period.", "interactions": "Interaction noted with palmitic acid (C16:0) supplementation.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:49.919935+00:00"}
{"study_id": 6982, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine if magnetotactic bacteria (MTB) could alleviate membrane fouling in ultrafiltration systems and improve the removal of Cr6+ from water.", "results_summary": "The study found that MTB reduced transmembrane pressure by 5 kPa under a magnetic field, improved Cr6+ removal by 14.56% compared to conventional ultrafiltration, and increased chromaticity removal by 10%. MTB also became the predominant flora, enhancing system efficiency.", "population_specificity": "Surface water treatment systems", "effective_dosage": "Cr6+ concentration: 10 mg/L; MTB dosage: 10 mg/L", "study_duration": "90 minutes", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:50.758472+00:00"}
{"study_id": 6983, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether fulvic acid (FA) application could mitigate chromium stress in maize by enhancing antioxidant activity and growth parameters.", "results_summary": "Chromium stress reduced chlorophyll content and increased oxidative stress markers (MDA, electrolyte leakage), but FA application improved chlorophyll content by 15% and reduced MDA levels by 40% under high chromium conditions. FA also boosted antioxidant enzyme activities and total soluble protein levels.", "population_specificity": "Two maize varieties (P3939 and 30Y87) grown under chromium stress.", "effective_dosage": "Chromium stress induced by CrCl3\u00b76H2O at 300 \u00b5M and 100 \u00b5M concentrations.", "study_duration": "5 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:53.494714+00:00"}
{"study_id": 6984, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare ceramic bonding characteristics of cobalt-chromium (Co-Cr) alloys fabricated by different methods (casting, milling, additive manufacturing) against zirconia and nickel-chromium (Ni-Cr).", "results_summary": "The study found that ceramic adhesion varied significantly among Co-Cr groups, with cast Co-Cr showing the highest adhesion and milled Co-Cr the lowest. Thermocycling did not affect results, and failure types differed by alloy and manufacturing technique.", "population_specificity": "Not applicable (in vitro study using alloy specimens).", "effective_dosage": "Not applicable.", "study_duration": "Not applicable (thermocycling involved 5000 cycles).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:54.355502+00:00"}
{"study_id": 6985, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of single and multi-domain microbial consortia encapsulated in alginate for bioremediation of Chromium [Cr(VI)]-contaminated soil.", "results_summary": "Fungal treatments showed higher Cr(VI) tolerance and reduction than bacterial treatments, while combined fungal-bacterial applications were more effective. Encapsulation improved microbial lifespan and Cr(VI) degradation, and consortia enhanced soil health by altering pH, conductivity, and enzyme activity.", "population_specificity": "Soil microbial communities (bacteria and fungi) in Cr(VI)-contaminated environments.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:54.826600+00:00"}
{"study_id": 6986, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of a ternary magnetic heterojunction photocatalyst (CZZ) in reducing Cr(VI) in aqueous environments.", "results_summary": "The CZZ photocatalyst demonstrated a significantly higher Cr(VI) reduction rate compared to single-component and binary photocatalysts, with excellent reusability over three cycles, suggesting its potential for practical wastewater treatment.", "population_specificity": "Aqueous matrices (not human or animal subjects).", "effective_dosage": "Not specified (photocatalyst performance measured by reduction rate, not dosage).", "study_duration": "Not specified (study focused on catalytic cycles, not time duration).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:55.433492+00:00"}
{"study_id": 6987, "supplement_id": 1022, "safety_score": "20", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of zinc-lysine and iron-lysine, both individually and combined, on mitigating chromium toxicity in pearl millet by assessing growth, physiological, and biochemical responses.", "results_summary": "Chromium stress negatively impacted pearl millet growth and physiological functions, but combined zinc-lysine and iron-lysine application significantly reduced oxidative stress, improved photosynthetic efficiency, and enhanced nutrient uptake while decreasing chromium accumulation in shoots and roots.", "population_specificity": "Pearl millet plants under chromium stress conditions.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:56.940880+00:00"}
{"study_id": 6988, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of thermochemical and co-precipitation magnetization methods on jackfruit peel-activated carbon's properties and its efficacy in adsorbing Chromium (VI) from wastewater.", "results_summary": "The study found that co-precipitation adsorbents had higher mesoporous structure and specific surface area, making them more effective for Cr(VI) adsorption. The thermochemical method produced adsorbents with stronger Fe-O-C bonds and varied iron oxide particles, but co-precipitation adsorbents showed better magnetite properties and higher iron oxide distribution.", "population_specificity": "Not applicable (in vitro study using adsorbents derived from jackfruit peel).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:57.674495+00:00"}
{"study_id": 6989, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare the shear bond strength of cobalt-chromium crowns on Corticobasal\u00ae implant abutments using different surface treatments and luting agents.", "results_summary": "Laser etching combined with GC Fuji Plus cementation yielded the highest shear bond strength (243.15 MPa), significantly outperforming untreated crowns (124.24 MPa). Sandblasting also improved bond strength, though less effectively than laser treatment.", "population_specificity": "In-vitro study (no human or animal subjects).", "effective_dosage": "Not applicable (material testing).", "study_duration": "Simulated oral conditions via 1000 thermocycles (5 \u00b0C-55 \u00b0C).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:58.730653+00:00"}
{"study_id": 6990, "supplement_id": 1022, "safety_score": "10", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the adverse effects of hexavalent chromium (Cr(VI)) on metaphase II oocytes, including DNA damage, cytoskeletal defects, and pluripotency protein expression during early embryonic development.", "results_summary": "The study found that Cr(VI) exposure causes DNA damage, impairs DNA repair mechanisms, and disrupts the cytoskeletal network (F-actin and microtubules) in metaphase II oocytes, leading to compromised oocyte quality and potential infertility. It also demonstrated adverse effects on early embryonic development by altering pluripotency protein markers (Oct4, Nanog, Cdx2).", "population_specificity": "Rats (in vivo and in vitro models)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:00.144419+00:00"}
{"study_id": 6991, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the performance of cobalt-chromium balloon-expandable stents versus stainless steel stents for treating iliac occlusive disease.", "results_summary": "The study found no significant differences in safety or efficacy outcomes between cobalt-chromium and stainless steel stents at 12 months, though technical success was lower with cobalt-chromium due to procedural complications like stent deformation.", "population_specificity": "Patients with symptomatic iliac occlusive disease (mean age ~66 years, 34.6% female).", "effective_dosage": "Not applicable (stent implantation, not oral supplementation).", "study_duration": "12-month follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:03.009137+00:00"}
{"study_id": 6992, "supplement_id": 1022, "safety_score": "20", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to examine the effects of chromium (Cr) contamination in soil on rice plants and evaluate the potential of nanoparticles (nCuO, nSi, nZnO) to mitigate these effects.", "results_summary": "Elevated chromium levels in wastewater reduced plant growth, photosynthetic pigments, and gas exchange while increasing oxidative stress markers. Nanoparticle application improved plant growth, reduced oxidative stress, and enhanced enzymatic and non-enzymatic antioxidant responses.", "population_specificity": "Rice plants (Oryza sativa L.)", "effective_dosage": "Wastewater concentrations of 50% and 100%", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:03.282224+00:00"}
{"study_id": 6994, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of chromium supplementation on serum levels of inflammatory markers (CRP, TNF-\u03b1, and IL-6) in adults aged 18 years and older.", "results_summary": "Chromium supplementation significantly reduced serum levels of CRP and TNF-\u03b1 but had a non-significant effect on IL-6. The study noted that formulation, BMI, sample size, and geographical region influenced outcomes.", "population_specificity": "Adults aged 18 years and older.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:04.388436+00:00"}
{"study_id": 6993, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of the chromium-histidine complex [Cr(hist)3] on reproductive success, developmental processes, and oxidative stress defense in Drosophila melanogaster.", "results_summary": "Cr(hist)3 at 15 \u00b5g/ml enhanced reproductive health (15.6% increase in fecundity, 15.5% in fertility), improved developmental efficiency (7.6% shorter larval period, 7.1% shorter pupal period), and upregulated antioxidant enzyme activity while reducing lipid peroxidation. Flies also exhibited a 9.7% increase in lifespan.", "population_specificity": "Wild-type Drosophila melanogaster (fruit flies)", "effective_dosage": "5, 10, 15, and 20 \u00b5g/ml (optimal effects at 15 \u00b5g/ml)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:04.812500+00:00"}
{"study_id": 6996, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of chitosan hydrogel microspheres loaded with Bacillus subtilis in mitigating plant stress caused by Chromium contamination and improving agricultural productivity.", "results_summary": "The treatment increased shoot biomass by 88% and reduced plant Chromium concentration by 17%. It also enhanced organic matter decomposition, nutrient uptake, and the abundance of anti-heavy metal stress functional bacteria.", "population_specificity": "Plants (specific species not mentioned)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:04.882702+00:00"}
{"study_id": 6995, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the phytoremediation capacity of Cosmos bipinnatus in chromium (Cr)-contaminated soil along the Dravyavati River in Jaipur.", "results_summary": "Cosmos bipinnatus showed efficient chromium absorption, particularly in treatments H2 (80% Nala soil + 20% wheat husk) and H3 (70% Nala soil + 30% wheat husk), with translocation factors >1 but bioaccumulation factors <1. Root uptake exceeded shoot uptake, indicating the plant's potential as a phytoextractor for Cr under specific conditions.", "population_specificity": "Soil contaminated with chromium along the Dravyavati River in Jaipur.", "effective_dosage": "Not specified (soil treatments described as percentages).", "study_duration": "20, 40, 60, and 80 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:06.952196+00:00"}
{"study_id": 6997, "supplement_id": 1022, "safety_score": "10", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how melatonin (MT) interacts with nitric oxide (NO) to regulate sulfur metabolism and enhance cotton plant resilience under chromium (Cr) toxicity.", "results_summary": "Cr toxicity impaired plant growth, photosynthesis, and induced oxidative stress, but MT treatment mitigated these effects by enhancing antioxidant activity, reducing Cr accumulation, and promoting sulfur-based defense substances. The study also found that inhibitors of MT biosynthesis and NO scavengers reversed these protective effects, suggesting NO plays a signaling role in Cr resistance.", "population_specificity": "Cotton plants exposed to chromium toxicity.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Inhibitors of MT biosynthesis (p-CPA) and NO scavenger (cPTIO) hindered MT's protective effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:08.438783+00:00"}
{"study_id": 6998, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a spiking method protocol could distinguish leathers with high and low risks of releasing hexavalent chromium (Cr(VI)).", "results_summary": "Group B leathers (low-risk) completely reduced all spiked Cr(VI), while group A leathers (high-risk) retained detectable Cr(VI) levels, dependent on initial spiking concentration and leather type. The 10 mg/kg spiking method effectively distinguished between high- and low-risk leathers.", "population_specificity": "Leather samples categorized by previous Cr(VI) detection (group A) and optimal tanning practices (group B).", "effective_dosage": "Up to 10 mg/kg of Cr(VI) spiked into leather samples.", "study_duration": "24-hour incubation at 80\u00b0C.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:09.504006+00:00"}
{"study_id": 6999, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the mechanical properties of cobalt-chromium posts in post-endodontic restoration compared to other materials.", "results_summary": "Cobalt-chromium posts demonstrated the highest maximal force (323.2 \u00b1 10.5 N) and bent rather than fractured, indicating superior mechanical performance under stress compared to quartz fiber and zirconium oxide posts.", "population_specificity": "Not specified (in vitro study on material specimens).", "effective_dosage": "Not applicable (mechanical testing, not consumption).", "study_duration": "Not specified (single testing session).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:11.258283+00:00"}
{"study_id": 7001, "supplement_id": 1022, "safety_score": "15", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether bilobetin (BLB) could mitigate chromium (Cr)-induced hepatotoxicity by modulating specific signaling pathways.", "results_summary": "Chromium administration caused significant liver damage, increasing oxidative stress markers, inflammatory cytokines, and hepatic enzymes while reducing protective gene expression. BLB treatment effectively reversed these effects, demonstrating hepatoprotective potential through molecular and histological improvements.", "population_specificity": "Male albino rats (n=36)", "effective_dosage": "Cr (10 mg/kg), BLB (12 mg/kg)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:12.719846+00:00"}
{"study_id": 7002, "supplement_id": 1022, "safety_score": "60", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to compare salivary chromium concentrations in individuals with and without dental restorations containing metal alloys to assess potential cytopathological effects.", "results_summary": "The study found higher chromium levels in non-stimulated saliva of patients with metal dental restorations, but no difference in stimulated saliva. A correlation between chromium and cobalt concentrations was observed.", "population_specificity": "Individuals aged 18-65 years with or without fixed prosthetic restorations made of metal alloys.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:13.136981+00:00"}
{"study_id": 7000, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of magnetic composite beads (OAF and NAF) synthesized from fruit peels and alginate for removing Cr (VI) ions from aqueous solutions.", "results_summary": "The study found that OAF and NAF had high adsorption capacities (224.3 mg/g and 256.5 mg/g, respectively) for Cr (VI) removal, followed pseudo-second order kinetics, and were reusable for at least five cycles with stable performance. The adsorption process was endothermic, spontaneous, and best fit the Langmuir isotherm model.", "population_specificity": "Aqueous solutions contaminated with Cr (VI) ions.", "effective_dosage": "Not specified (adsorption capacities measured at 298 K and pH = 2.0).", "study_duration": "Not specified (adsorption process duration not detailed).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:13.331836+00:00"}
{"study_id": 7003, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether \u03b3-PGA could reduce chromium (Cr) and copper (Cu) toxicity in cucumber plants and whether this effect was linked to changes in the rhizosphere microbiome.", "results_summary": "\u03b3-PGA significantly reduced Cr and Cu content in cucumber plants, alleviated oxidative stress, and increased fruit biomass. It also altered the rhizosphere bacterial community, enriching taxa involved in heavy metal passivation and plant growth promotion.", "population_specificity": "Cucumber plants grown in Cr- and Cu-contaminated soil.", "effective_dosage": "Not specified", "study_duration": "20 weeks (for chelate stability assessment)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:13.541591+00:00"}
{"study_id": 7004, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of an autotrophic bioreduction technology using biochar-assisted zero valent iron (ZVI) for simultaneous removal of Cr(VI) and NO3- from groundwater.", "results_summary": "The ZVI + BC500 biotic column achieved 100% removal efficiency for Cr(VI) and 93.37% for NO3- over 11 weeks, significantly outperforming ZVI alone. The improved electron transfer and microbial activity facilitated Cr(VI) reduction and denitrification while mitigating pore clogging risks.", "population_specificity": "Groundwater (environmental study, not human subjects)", "effective_dosage": "Initial concentrations of 26 mg/L Cr(VI) and 50 mg/L NO3-", "study_duration": "11 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:16.310855+00:00"}
{"study_id": 7005, "supplement_id": 1022, "safety_score": "75", "efficacy_score": 68, "quality_score": 82, "study_goal": "The researchers aimed to evaluate the relationship between trivalent chromium (Cr(III)) supplementation and its effects on glycemic control and lipid profile in the context of type 2 diabetes mellitus (T2DM).", "results_summary": "Chromium supplementation showed significant improvements in glycemic control markers (FPG, insulin, HbA1C, HOMA-IR) and lipid profile (increased HDL, decreased triglycerides and total cholesterol), though results were inconsistent due to variations in dosage, formulation, and study duration.", "population_specificity": "Individuals with or at risk of type 2 diabetes mellitus.", "effective_dosage": "50\u20131000 \u03bcg/day", "study_duration": "2\u20136 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:16.846269+00:00"}
{"study_id": 7006, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the adsorption capacity of a polyethylenimine-silica composite material (SiO\u2082-PEI) for removing chromate and arsenate ions from water.", "results_summary": "The SiO\u2082-PEI material showed higher adsorption capacity for chromate and arsenate ions at pH 4, with adsorption being an exothermic process more favorable at lower temperatures. The presence of other anions like phosphate, nitrate, and sulfate reduced adsorption capacity, with arsenate more affected than chromate.", "population_specificity": "Not applicable (in vitro study on water/wastewater treatment).", "effective_dosage": "Not applicable (adsorption study, no dosage specified).", "study_duration": "Not specified.", "interactions": "Presence of other anions (phosphate, nitrate, sulfate) affected adsorption capacity.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:19.305344+00:00"}
{"study_id": 7007, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop an energy-efficient method for capturing and detoxifying toxic Cr(VI) by converting it to less harmful Cr(III) using a combination of ferrocene, carboxymethyl cellulose, and polyethyleneimine.", "results_summary": "The combination of ferrocene, carboxymethyl cellulose, and polyethyleneimine significantly improved Cr(VI) adsorption capacity (280.5 mg/g) and achieved an 85.4% reduction rate of Cr(VI) to Cr(III) under electrochemical conditions. The synergistic effect enhanced electronic and ionic transportation, specific capacitance, and electrode-electrolyte interactions.", "population_specificity": "Not specified (laboratory study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:20.982332+00:00"}
{"study_id": 7010, "supplement_id": 1022, "safety_score": "20", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize the forms of chromium in solid wastes, redox reaction mechanisms, and methods to inhibit Cr(VI) formation during thermal treatment.", "results_summary": "The study found that Cr(III) in solid wastes can oxidize to highly toxic Cr(VI) at high temperatures, with oxidation mechanisms influenced by system basicity and temperature. Adding acidic oxides like silicon dioxide reduced Cr(VI) formation.", "population_specificity": "Industrial solid wastes (tannery sludge, electroplating sludge, metallurgical slag).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:21.628357+00:00"}
{"study_id": 7009, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine if chromium supplementation, alone or combined with phytase, could improve nutrient digestibility and blood metabolites in grower pigs.", "results_summary": "Supplemental chromium had no significant effect on fasting or postprandial glucose, insulin levels, or nitrogen and dry matter digestibility. The study found no synergistic benefits when chromium was combined with phytase.", "population_specificity": "Genesus terminal genetics grower pigs (20.7 kg)", "effective_dosage": "200 parts per billion (ppb) of chromium from chromium tripicolinate", "study_duration": "1 week per treatment period (4 periods total)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:21.659343+00:00"}
{"study_id": 7008, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine how impaired skin barrier function, caused by hand hygiene practices, affects the retention of allergenic metals like chromium.", "results_summary": "The study found that chromium retention in skin was higher when the skin barrier was impaired by sodium lauryl sulphate (SLS). Co-exposure to nickel, cobalt, and chromium in 0.5% SLS resulted in the highest total metal retention.", "population_specificity": "In vitro experiments using full-thickness skin from stillborn piglets.", "effective_dosage": "Not specified (exposure to metals dissolved in Milli-Q water, 0.5% SLS, and ethanol).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:21.989184+00:00"}
{"study_id": 7011, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of sulfidated nano zerovalent iron on biochar (S-nZVI@BC) for rapid removal of Cr(VI) from water.", "results_summary": "S-nZVI@BC demonstrated excellent dispersion and transport properties, efficiently removing Cr(VI) in the pH range of 2.5-5.0, with 42.0% of Cr adsorbed within 30 minutes. The material showed strong reusability, resistance to interference, and potential for reactivation in continuous removal applications.", "population_specificity": "Not applicable (in vitro/environmental study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:22.367745+00:00"}
{"study_id": 7012, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the microstructural changes in chromium-containing alloys (CoCr and NiCr) after ceramic layering and assess their bonding potential and mechanical stability.", "results_summary": "Ceramic-layering reduced grain size in milled alloys but increased it in cast alloys, while surface roughness increased in cast CoCr and NiCr groups but slightly decreased in zirconia. The study demonstrated close bonding interfaces and significant microstructural changes, enhancing mechanical stability.", "population_specificity": "Not specified (in vitro study using alloy discs).", "effective_dosage": "Not applicable (material testing, not consumption).", "study_duration": "Not specified (single-time analysis post-processing).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:25.596839+00:00"}
{"study_id": 7013, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether anaerobic methanotrophic archaea (ANME) could couple anaerobic oxidation of methane (AOM) to chromium (VI) reduction and identify the biochemical mechanisms involved.", "results_summary": "The study found that a consortium dominated by \"Ca. Methanoperedens\" effectively reduced Cr(VI) to Cr(III) via extracellular respiratory pathways, with multiheme cytochrome c proteins playing a key role. A formate-dependent nitrite reductase was also implicated in intracellular Cr(VI) reduction.", "population_specificity": "Anaerobic methanotrophic archaea (ANME) consortium, specifically \"Ca. Methanoperedens.\"", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:25.789296+00:00"}
{"study_id": 7014, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether chitosan (CTS) and salicylic acid (SA) could mitigate chromium (Cr)-induced stress in Aconitum napellus plants.", "results_summary": "The study found that foliar application of CTS and SA, individually and combined, significantly improved growth, chlorophyll content, and physiological parameters in Cr-stressed A. napellus, with the combined treatment showing the most pronounced benefits.", "population_specificity": "Aconitum napellus (a medicinal and floricultural plant)", "effective_dosage": "CTS (0.4 g/L) or SA (0.25 mmol/L) applied foliarly", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:27.913454+00:00"}
{"study_id": 7015, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of sol-gel-functionalized polyurethane foams (PUFs) for the complete extraction of chromium (VI) species from aqueous media.", "results_summary": "The study demonstrated that sol-gel-treated PUFs effectively extracted chromium (VI) with a high uptake capacity (9.9 mg\u00b7g\u207b\u00b9), fitting well with the Langmuir adsorption model and pseudo first-order kinetics. The process was endothermic and spontaneous, with successful application in removing trace chromium (VI) from water samples.", "population_specificity": "Aqueous media (water samples)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:29.930001+00:00"}
{"study_id": 7016, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of chromium (Cr) supplementation, alone or combined with palmitic acid (PA), on insulin sensitivity and lipid metabolism in adipose tissue of periparturient dairy cows.", "results_summary": "Chromium supplementation improved systemic insulin sensitivity, reduced postpartum NEFA concentrations, increased large adipocyte percentage, and enhanced ex vivo antilipolytic effects of insulin in adipose tissue. However, Cr+PA did not show synergistic benefits and PA increased macrophage infiltration.", "population_specificity": "Multiparous periparturient dairy cows (n=32).", "effective_dosage": "Cr propionate at 0.45 mg/kg Cr/kg DM.", "study_duration": "24 days postpartum.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:30.824182+00:00"}
{"study_id": 7018, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare marginal bone loss and soft tissue health around two-implant mandibular overdentures retained with milled versus selective laser-melted cobalt chromium (Co-Cr) bars.", "results_summary": "No significant difference in marginal bone loss was found between the two groups, though the milled group showed increased bone loss from 0-6 months. Probing depth was significantly lower in the milled group at 6- and 12-month follow-ups, while plaque and gingival indices showed no significant differences between groups.", "population_specificity": "Completely edentulous patients receiving two-implant mandibular overdentures.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:32.041193+00:00"}
{"study_id": 7019, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop a novel 3D-printed bio-accelerator system to mitigate Cr(VI) inhibition in denitrification systems and enhance wastewater treatment efficiency.", "results_summary": "The 3D-printed bio-accelerators (3DP-B) demonstrated sustained release for at least 144 hours, significantly improving recovery time, COD and NO3--N removal efficiency, and maintaining high enzyme activity and electron transport capacity. The addition of 60 mg\u00b7L-1 AQDS showed superior bio-inhibition release and enhanced electron transport compared to higher concentrations.", "population_specificity": "Denitrification biofilm systems in wastewater treatment.", "effective_dosage": "60 mg\u00b7L-1 anthraquinone-2,6-disulfonate (AQDS).", "study_duration": "At least 144 hours (6 days).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:32.308524+00:00"}
{"study_id": 7017, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to develop and evaluate an integrated technology (BMED-H2O2 oxidation) for recovering Cr(III) from chromium electroplating sludge (EPS) and reducing its environmental harm.", "results_summary": "The study achieved a 68.4% Cr(III) oxidation ratio under optimal conditions (H2O2 dosage: 5.5 mL, pH: 12.0) and recovered 58.2% of Cr(III) as Na2CrO4. Increasing the number of EPS compartments reduced energy consumption without affecting current efficiency, and the remaining Cr(III) in sludge was in a less harmful residual state.", "population_specificity": "Chromium electroplating sludge (EPS) and chromium-containing solid wastes.", "effective_dosage": "H2O2 dosage: 5.5 mL, current density: 20.0 mA/cm2, solid/liquid ratio: 1.0:45, sludge particle size: 100 mesh.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:32.917465+00:00"}
{"study_id": 7021, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to develop a system for Cr(VI) detoxification and simultaneous on-site H2O2 generation in industrial wastewater treatment.", "results_summary": "The system achieved complete reduction of 10-100 ppm Cr(VI) and enhanced H2O2 production by 10.6-88.1% compared to Cr(VI)-free conditions, demonstrating high efficiency and stability over 24 days.", "population_specificity": "Industrial wastewater (not human or animal subjects).", "effective_dosage": "10-100 ppm Cr(VI) in electrolyte.", "study_duration": "24-day continuous experiment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:34.412482+00:00"}
{"study_id": 7020, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of graphene oxide-doped nanocomposites, including chromium-based materials, for dye removal in wastewater treatment.", "results_summary": "The study found that graphene oxide-doped cobalt and iron-doped lanthanum chromium titanate (GO/Co.Fe.LaCrO3) showed effective dye adsorption under optimal conditions, with varying adsorption capacities depending on pH, dosage, shaking time, and temperature. The pseudo-second-order adsorption isotherm and Langmuir isotherm provided good fits for the adsorption process.", "population_specificity": "Not specified (laboratory study on wastewater treatment materials).", "effective_dosage": "Adsorbent dose of 0.01 g/50 mL for GO/Co.Fe.LaCrO3.", "study_duration": "Not specified (experimental conditions varied by parameter).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:35.420047+00:00"}
{"study_id": 7022, "supplement_id": 1022, "safety_score": "10", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of citric acid and a Cr-reducing bacterial strain (Staphylococcus aureus) in enhancing the phytoextraction potential of Lemna minor for chromium detoxification in tannery wastewater.", "results_summary": "The study found that citric acid and Staphylococcus aureus inoculation significantly improved chromium uptake and accumulation in Lemna minor, enhancing growth, chlorophyll content, antioxidant enzyme activities, and nutrient uptake. The combination of citric acid (5-10 mM) and bacterial inoculation further increased chromium concentration and accumulation.", "population_specificity": "Lemna minor (duckweed) in a Constructed Wetland System treated with tannery wastewater.", "effective_dosage": "Citric acid (0, 5, 10 mM) and tannery wastewater (0, 50, 100%).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:38.123754+00:00"}
{"study_id": 7023, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of pump-and-treat (PAT) technology in remediating Cr(VI) contamination at a smelter site and assess its long-term impact on pollution plume distribution.", "results_summary": "The study found that PAT technology effectively removed Cr(VI) in highly polluted areas (>160 mg/L) within six months but failed to prevent plume incursion into downstream residential areas after 20 years. Adding supplementary pumping wells reduced the pollution area by 20-41% over the same period.", "population_specificity": "Contaminated smelter site with Cr(VI) pollution.", "effective_dosage": "Not specified", "study_duration": "6 months for initial remediation, 20 years for long-term simulation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:39.258809+00:00"}
{"study_id": 7024, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to analyze the migration path and mechanism of Chromium (Cr) in hydrochar during the hydrothermal carbonization (HTC) process of Chinese medicine residue (CMR).", "results_summary": "The study found that Cr migration in hydrochar occurs in two stages: accompanying migration and recovery aggregation. Hydrolysis, decarboxylation, and decarbonylation drive Cr migration, while aromatization causes Cr recovery and aggregation, with Cr potentially catalyzing aromatic structure formation in hydrochar.", "population_specificity": "Licorice (a Chinese medicine) residue subjected to HTC.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:39.420979+00:00"}
{"study_id": 7025, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of biohybrid membrane systems for removing chromium and arsenic from contaminated environments.", "results_summary": "PVA and PVA-magnetite biohybrid membranes removed over 80% of chromium from synthetic liquid media within 48 hours. PVA and PBAT membranes also reduced arsenic translocation to edible plant parts.", "population_specificity": "Synthetic liquid media and soybean (Glycine max L.) seedlings.", "effective_dosage": "Initial concentrations of 5 ppm hexavalent chromium.", "study_duration": "48 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:39.793382+00:00"}
{"study_id": 7026, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate how post-heat treatment processes affect texture, hydrogen content, residual stress, and corrosion resistance in hexavalent chromium coatings on Cr-Ni-Mo-V steel substrates.", "results_summary": "Heat treatment at 380 \u00b0C for 4 h reduced hydrogen content and residual stress by 86% and 75%, respectively, while improving corrosion resistance and microhardness. Texture strength and crack density were less affected by heat treatment time.", "population_specificity": "Cr-Ni-Mo-V steel substrates with hexavalent chromium coatings.", "effective_dosage": "Not applicable (material science study).", "study_duration": "Heat treatment applied for 4 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:41.507635+00:00"}
{"study_id": 7027, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of a marine fungal strain (Rhodotorula sp. MZ312369) in remediating Chromium (Cr6+) and Zinc (Zn2+) from wastewater using a calcium carbonate bioprecipitation technique.", "results_summary": "The study demonstrated complete removal of Cr6+ (400 ppm) at 168 hours, with high carbonic anhydrase enzyme activity (140 U/mL) and Ca2+ removal (85.06%). Mineralogical analysis confirmed encapsulation of Cr6+ within vaterite bioliths.", "population_specificity": "Marine fungal strain (Rhodotorula sp. MZ312369) in a controlled laboratory setting.", "effective_dosage": "400 ppm Cr6+ concentration.", "study_duration": "168 hours (7 days).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:42.851656+00:00"}
{"study_id": 7028, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the speciation, bioavailability, and fate of Chromium (Cr) in sewage sludge-derived biochar (SSB) after land application.", "results_summary": "Approximately 58% of Cr in sewage sludge was transformed into Fe (hydr)oxide-bound Cr(III) during pyrolysis, but immobilized Cr in SSB tended to slowly remobilize in soil over time, posing potential risks as a metal(loid) source. SSB reduced metal(loid) translocation from soil to crops compared to raw sewage sludge.", "population_specificity": "Soil and crops (specific crop type not mentioned).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:43.269991+00:00"}
{"study_id": 7029, "supplement_id": 1022, "safety_score": "20", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effects of nutraceuticals (PHL, BCA, and CoQ10) against chromium and arsenic-induced hepatotoxicity in mice.", "results_summary": "Chromium and arsenic exposure increased hepatotoxicity, oxidative stress, and apoptosis in mice, while the nutraceutical combination restored antioxidant activity, improved gene expression markers (SIRT1, Nrf2, HO-1, NQO1), and reduced apoptosis.", "population_specificity": "Swiss albino mice", "effective_dosage": "Potassium dichromate (75 ppm) in drinking water", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:44.781254+00:00"}
{"study_id": 7030, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of layered double hydroxides (LDH-D) and their calcined derivatives in immobilizing chromium (Cr(VI)) in contaminated soil.", "results_summary": "LDH-D, especially when calcined at 500\u00b0C (LDH-D-500), effectively immobilized Cr(VI) in soil through mechanisms like interlayer anion exchange, surface adsorption, and structural recovery. Long-term experiments confirmed reduced soil-to-plant transmission of Cr(VI) and microbial community adaptation, indicating durable immobilization.", "population_specificity": "Contaminated soil (no human or animal subjects).", "effective_dosage": "Not specified (material-based intervention).", "study_duration": "Long-term TCLP experiments (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:47.102070+00:00"}
{"study_id": 7031, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 95, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the effectiveness of a nanocomposite (RAAC/AABC/GO/Fe3O4) for chromium removal from aqueous solutions.", "results_summary": "The nanocomposite achieved a chromium removal efficiency of 99.91% under optimal conditions (pH 6, 70 mg/L initial Cr (VI) concentration, 90 min contact time, 1 g/200 mL adsorbent dose). The Langmuir isotherm and pseudo-second-order kinetics models best described the adsorption process.", "population_specificity": "Aqueous solutions contaminated with chromium (Cr (VI)).", "effective_dosage": "Adsorbent doses of 0.5, 0.75, and 1 g/200 mL were tested.", "study_duration": "Contact times ranged from 60 to 120 minutes.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:48.778841+00:00"}
{"study_id": 7032, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of magnetite nanoparticles (nano-Fe3O4) and nano-Fe3O4 immobilized with bacterial extracellular polymeric substances (EPS) in removing Cr (VI) from aqueous solutions under varying acidic conditions.", "results_summary": "The study found that 5 g/L of nano-Fe3O4 effectively removed 89.2% of Cr (VI) at pH 4 within 5 hours, following a pseudo-second-order model. The immobilized nano-Fe3O4 with bacterial EPS showed stable Cr (VI) removal across a wide range of acidic conditions, with EPS concentration not significantly affecting efficiency.", "population_specificity": "Aqueous solutions (in vitro study)", "effective_dosage": "5 g/L of nano-Fe3O4", "study_duration": "5 hours (equilibrium time)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:49.548103+00:00"}
{"study_id": 7033, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of biomass-derived activated carbons (CSAC, RHAC, WHAC) in removing hexavalent chromium (Cr6+) from solutions.", "results_summary": "CSAC demonstrated high adsorption efficiency (255.4 mg.g-1) for Cr(VI) removal, with optimal conditions at pH 3 and a dosage of 200 mg.L-1. The adsorption process was endothermic and followed hybrid mechanisms involving chemisorption and van der Waals forces.", "population_specificity": "Not applicable (in vitro study using activated carbons and synthetic solutions).", "effective_dosage": "200 mg.L-1 of activated carbon.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:49.921822+00:00"}
{"study_id": 7035, "supplement_id": 1022, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of fly ash loaded nano-FeS composite (nFeS-FA) in removing chromium (Cr(VI) and total Cr) from wastewater.", "results_summary": "Under optimal conditions (8 g/L nFeS-FA, pH 4, 150 min contact time, 100 mg/L initial concentration), nFeS-FA achieved 87.85% removal of Cr(VI) and 71.77% removal of total Cr, with adsorption following the Langmuir model and pseudo-second-order kinetics. The composite exhibited excellent adsorption performance due to uniform dispersion of nano-FeS on fly ash, increasing surface area and facilitating chemical adsorption.", "population_specificity": "Chromium-containing wastewater (not human or animal subjects).", "effective_dosage": "8 g/L nFeS-FA.", "study_duration": "150 minutes (contact time).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:51.949861+00:00"}
{"study_id": 7036, "supplement_id": 1022, "safety_score": "20", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the mechanisms of hexavalent chromium (Cr(VI))-induced small intestinal toxicity, focusing on the role of PP2A A\u03b1 deficiency and the Hippo/YAP1 signaling pathway.", "results_summary": "Cr(VI) exposure caused crypt hyperplasia, epithelial cell apoptosis, and intestinal barrier dysfunction in mice, with effects worsened by PP2A A\u03b1 deficiency. Urolithin A was found to attenuate Cr(VI)-induced intestinal barrier disruption by modulating YAP1 expression and activity.", "population_specificity": "Mice with intestinal epithelium-specific knockout of Ppp2r1a (PP2A A\u03b1 subunit) and wild-type littermates.", "effective_dosage": "0, 5, 20, and 80 mg/l Cr(VI) for 28 days.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:53.397119+00:00"}
{"study_id": 53514, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the association between obstructive sleep apnea and hypertension, and the potential of Continuous Positive Airway Pressure (CPAP) to lower blood pressure and improve BP dipping.", "results_summary": "The study found that moderate to severe obstructive sleep apnea is associated with hypertension, particularly resistant hypertension, and abnormal 24-hour ambulatory BP profiles. CPAP treatment may lower BP and improve BP dipping.", "population_specificity": "Patients with obstructive sleep apnea, particularly those with hypertension or resistant hypertension.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:01.097550+00:00"}
{"study_id": 53517, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the bidirectional relationship between chronic kidney disease and obstructive sleep apnea and assess the role of Continuous Positive Airway Pressure (CPAP) in mitigating associated health risks.", "results_summary": "CPAP therapy was identified as the mainstay treatment for reversing the health risks of sleep apnea, including oxidative stress, inflammation, and sympathetic activation. Other strategies like weight loss, oral appliances, and corrective surgery were also mentioned as adjunctive measures.", "population_specificity": "Patients with chronic kidney disease and obstructive sleep apnea.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:01.235529+00:00"}
{"study_id": 53519, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to determine whether effective CPAP treatment reduces the risk of acute exacerbation of COPD (AECOPD) and mortality in patients with overlap syndrome (COPD and OSA).", "results_summary": "The study suggests that effective CPAP treatment may reduce the risk of AECOPD and mortality in patients with overlap syndrome, while improper treatment of insomnia may increase adverse respiratory outcomes in COPD patients.", "population_specificity": "Patients with chronic obstructive pulmonary disease (COPD) and overlap syndrome (COPD and obstructive sleep apnea).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:01.301581+00:00"}
{"study_id": 53516, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether Continuous Positive Airway Pressure (CPAP) reduces cardiovascular risk in patients with obstructive sleep apnea (OSA) and explore potential complementary therapies.", "results_summary": "CPAP effectively mitigated the apnea-hypopnea index and hypoxemia but did not significantly reduce cardiovascular events in recent randomized clinical trials. The review suggests exploring additional therapeutic targets, such as neurostimulation and the autonomic nervous system.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:01.318675+00:00"}
{"study_id": 53515, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of CPAP and MAS therapy on blood pressure variability (BPV) in patients with moderate to severe obstructive sleep apnoea (OSA).", "results_summary": "Neither CPAP nor MAS therapy improved BPV overall, but a subgroup of effectively treated CPAP patients showed a reduction in diastolic blood pressure variability. No difference was observed between effective and ineffective MAS treatment.", "population_specificity": "92 patients with moderate to severe OSA.", "effective_dosage": "Not specified", "study_duration": "One month for each therapy (CPAP and MAS).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:01.647806+00:00"}
{"study_id": 53518, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Continuous Positive Airway Pressure (CPAP) therapy improves blood pressure in patients with obstructive sleep apnea (OSA) and resistant hypertension (RH).", "results_summary": "CPAP therapy was associated with significant reductions in 24-hour, daytime, and nighttime systolic and diastolic blood pressure, as well as a mild reduction in aldosterone secretion, but showed no benefit for aortic stiffness.", "population_specificity": "Patients with obstructive sleep apnea (OSA) and resistant hypertension (RH).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:01.855719+00:00"}
{"study_id": 53521, "supplement_id": 1048, "safety_score": "50", "efficacy_score": 40, "quality_score": 60, "study_goal": "The researchers aimed to determine whether introducing oral feeding for infants and children on nasal continuous positive airway pressure (nCPAP) or high flow nasal cannula (HFNC) facilitates achieving full oral feeding without adverse effects compared to no oral feeding (NPO).", "results_summary": "The study found insufficient evidence to conclude whether oral feeding on nCPAP or HFNC aids in transitioning to full oral feeding safely. Adverse events were reported in 11 studies, but safety assessments were largely retrospective and lacked robust instrumental evaluations.", "population_specificity": "Children (preterm to <18 years) on nCPAP or HFNC who were orally feeding.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:02.465917+00:00"}
{"study_id": 53520, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 45, "study_goal": "The researchers aimed to evaluate whether restricted fluid therapy compared to standard fluid therapy reduces the need for noninvasive or invasive ventilation (including CPAP) and the duration of oxygen therapy in neonates with TTN.", "results_summary": "The study found very low certainty evidence, making it impossible to determine if fluid restriction affects the duration of oxygen therapy or the need for CPAP or mechanical ventilation. Outcomes were inconsistent, with high heterogeneity and risk of bias across trials.", "population_specificity": "Term and late preterm neonates diagnosed with transient tachypnea of the newborn (TTN) during the first week after birth.", "effective_dosage": "Infants in the fluid-restricted group received 15 to 20 mL/kg/d less fluid than controls.", "study_duration": "Varying durations after enrollment (not specified in detail).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:03.615537+00:00"}
{"study_id": 53522, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To assess whether transitioning premature infants from nasal continuous positive airway pressure (nCPAP) to heated humidified high-flow nasal cannula therapy (HFNC) affects cerebral oxygenation.", "results_summary": "The study found no significant difference in cerebral oxygenation between infants on nCPAP and those transitioning to HFNC (66% vs 66%), supporting the use of HFNC in preterm infants.", "population_specificity": "Premature infants with a median gestational age of 27 weeks and median birthweight of 924 g.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:09.246969+00:00"}
{"study_id": 53526, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to investigate the relationship between opioid use and obstructive sleep apnea (OSA), including the effects of OSA treatment in opioid users.", "results_summary": "The study found mixed results, with eight of 14 studies showing no significant link between opioid use and OSA severity. A meta-analysis indicated a small, non-significant mean change in AHI associated with opioid use.", "population_specificity": "Adults from clinical trials and observational studies (1946-2018).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:10.142201+00:00"}
{"study_id": 53528, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of hypoglossal nerve stimulation (HGNS) as an alternative therapy for obstructive sleep apnea in patients intolerant to continuous positive airway pressure (CPAP).", "results_summary": "The study found that HGNS therapy significantly reduced respiratory parameters like disordered breathing indices and improved subjective sleep complaints such as daytime sleepiness. It expanded treatment options for CPAP-intolerant patients.", "population_specificity": "Patients with obstructive sleep apnea who are intolerant to CPAP therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:10.405176+00:00"}
{"study_id": 53527, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess whether at-home continuous overnight pulse oximetry could diagnose moderate-to-severe OSA in bariatric surgery patients, potentially replacing more expensive methods like CRP or PSG.", "results_summary": "The study found that overnight pulse oximetry, particularly the oxygen desaturation index, was highly correlated with OSA diagnosis (sensitivity 80%, specificity 92%) and could effectively screen for moderate-to-severe OSA, allowing early CPAP therapy.", "population_specificity": "Patients scheduled for bariatric surgery with no prior OSA diagnosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:10.671697+00:00"}
{"study_id": 53529, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare treatment adherence between automatic positive airway pressure (APAP) and fixed continuous positive airway pressure (CPAP) in obstructive sleep apnea patients awaiting bariatric surgery.", "results_summary": "The study found no statistically significant differences in adherence at 1 month, efficacy parameters, adverse effects, quality of life, or peri-operative complications between APAP and CPAP. However, CPAP showed slightly lower adherence rates (86.0% vs. 96.9%) and average nightly use (5.9 hr vs. 6.3 hr) compared to APAP, though these differences were not clinically significant.", "population_specificity": "Obese patients newly diagnosed with severe obstructive sleep apnea and awaiting bariatric surgery.", "effective_dosage": "Not specified (fixed CPAP vs. automatic APAP settings).", "study_duration": "Pre-operatively until surgery (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:14.181354+00:00"}
{"study_id": 53530, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the therapeutic potential of anakinra (an IL-1 receptor antagonist) for COVID-19-associated ARDS, not Continuous Positive Airway Pressure.", "results_summary": "The study found that anakinra-treated COVID-19 ARDS patients had significantly higher 28-day survival (75.0%) compared to controls (48.2%). The abstract does not mention Continuous Positive Airway Pressure.", "population_specificity": "COVID-19 ARDS patients admitted to a hospital in Lecco, Italy, between March 5th and April 15th, 2020.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:18.131304+00:00"}
{"study_id": 53524, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential role of microRNAs (miRNAs) as biomarkers for the diagnosis and therapy allocation of obstructive sleep apnea (OSA), rather than directly evaluating Continuous Positive Airway Pressure (CPAP).", "results_summary": "The abstract does not provide specific findings about CPAP's effects but discusses the potential of miRNAs as novel indicators for managing OSA, highlighting gaps in research and proposing future steps for clinical integration.", "population_specificity": "Pediatric and adult OSA patients.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:19.487209+00:00"}
{"study_id": 53525, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness and adherence of Continuous Positive Airway Pressure (CPAP) compared to alternative therapies like hypoglossal nerve stimulation (HGNS) for treating obstructive sleep apnea (OSA).", "results_summary": "CPAP is the gold standard for treating OSA but has adherence rates between 20% and 80%. Hypoglossal nerve stimulation (HGNS) was found to be a very effective alternative for moderate and severe OSA in patients who cannot tolerate CPAP, with superior adherence.", "population_specificity": "Patients with obstructive sleep apnea (OSA), particularly those with moderate to severe cases who cannot tolerate CPAP.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:20.168751+00:00"}
{"study_id": 53532, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the performance of different utility instruments in assessing health-related quality of life in patients with obstructive sleep apnea syndrome (OSAS) undergoing CPAP therapy.", "results_summary": "After 2 years of CPAP therapy, significant improvements were observed in apnea-hypopnea index (AHI) and Epworth sleepiness score. The short-form 6-dimensions questionnaire, Euro-thermometer, and time trade-off instruments reflected these clinical improvements, while EuroQoL 5-dimensions and standard gamble tests were less sensitive to CPAP effects.", "population_specificity": "208 patients with OSAS (28 women, mean age 54.4 \u00b1 0.7 years, AHI 51.9 \u00b1 1.8/h, Epworth sleepiness score 13.4 \u00b1 0.2).", "effective_dosage": "Not specified", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:20.575961+00:00"}
{"study_id": 53531, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 70, "study_goal": "The researchers aimed to assess whether salbutamol is effective and safe compared to placebo, no treatment, or other drugs for treating transient tachypnea of the newborn in infants born at 34 weeks' gestational age or more.", "results_summary": "The study found limited and low-certainty evidence on salbutamol's effects, with uncertain reductions in the need for continuous positive airway pressure and mechanical ventilation, though it may slightly reduce hospital stay.", "population_specificity": "Infants born at 34 weeks' gestational age or more and less than three days of age with transient tachypnea of the newborn.", "effective_dosage": "Nebulized dose of salbutamol (varied: single dose in four studies, 3-4 doses in two studies, additional doses if needed in one study).", "study_duration": "Not specified beyond administration within the first three days of life.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:20.781162+00:00"}
{"study_id": 53523, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 50, "study_goal": "The researchers aimed to examine the association between sleep apnea (SA) and chronic kidney disease (CKD) progression, as well as the potential impact of continuous positive airway pressure (CPAP) on renal and cardiovascular outcomes in CKD and ESKD patients.", "results_summary": "The study found observational evidence linking SA to CKD incidence and progression, but no randomized clinical trials confirmed CPAP's efficacy in improving renal or cardiovascular outcomes in CKD/ESKD patients. Renal transplantation was noted as the most effective treatment for SA in ESKD patients, though SA re-emerged over time.", "population_specificity": "CKD and end-stage kidney disease (ESKD) patients with sleep apnea.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:21.256195+00:00"}
{"study_id": 53534, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the risks and benefits of CPAP for OSA patients during the Covid-19 pandemic, focusing on adherence and management.", "results_summary": "The abstract highlights CPAP as the mainstay treatment for moderate-severe OSA but notes that its benefits depend on medical expertise and patient adherence. Limited attention has been given to CPAP adherence and management in OSA patients exposed to Covid-19.", "population_specificity": "OSA patients, particularly those exposed to Covid-19.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:22.027890+00:00"}
{"study_id": 53535, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential benefits of Continuous Positive Airway Pressure (CPAP) in managing atrial fibrillation (AF) in patients with obstructive sleep apnea (OSA).", "results_summary": "The study suggests that CPAP treatment for OSA may help maintain sinus rhythm after electrical cardioversion and improve catheter ablation success rates in AF patients. However, the evidence is based on nonrandomized studies, indicating a need for further rigorous investigation.", "population_specificity": "Patients with atrial fibrillation and obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:26.196881+00:00"}
{"study_id": 53536, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to identify early predictors of CPAP failure in COVID-19 patients to avoid delayed intubation.", "results_summary": "The study found that age, lactate dehydrogenase (LDH) levels, and percentage change in PaO\u2082/FiO\u2082 ratio were significant predictors of CPAP failure, with these factors being lower in patients who successfully responded to CPAP.", "population_specificity": "COVID-19 patients with respiratory failure treated with out-of-ICU CPAP.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:27.103850+00:00"}
{"study_id": 53538, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the treatment effects of CPAP and titratable MAD on sleepiness, quality of life, sleep-disordered breathing severity, and sleep structure in patients with severe OSA.", "results_summary": "CPAP was more effective than MAD in reducing AHI and ODI, but both treatments had similar impacts on sleepiness, quality of life, and sleep structure (increased N3 and REM sleep). Treatment adherence and preference favored MAD.", "population_specificity": "Patients with severe obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:28.893331+00:00"}
{"study_id": 53537, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the cost-effectiveness of prehospital Continuous Positive Airway Pressure (CPAP) compared to standard oxygen therapy for Acute Respiratory Failure (ARF).", "results_summary": "The study found that prehospital CPAP's cost-effectiveness depends on effectiveness estimates\u2014standard oxygen therapy was cost-effective based on a small trial, while CPAP was cost-effective when using meta-analysis data. The value of further large-scale trials was supported.", "population_specificity": "Patients with undifferentiated Acute Respiratory Failure in a representative ambulance service.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:29.300122+00:00"}
{"study_id": 53540, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the impact of telemedicine interventions on improving adherence and efficacy of Continuous Positive Airway Pressure therapy.", "results_summary": "The study found that telemedicine interventions leveraging remote monitoring data can increase average usage and efficiency of care, but more evidence is needed on long-term adherence and patient-reported outcomes. Combining remote monitoring with clinical data may enhance future sleep medicine practice and research.", "population_specificity": "Patients using Continuous Positive Airway Pressure therapy (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:29.368559+00:00"}
{"study_id": 53541, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of positive airway pressure (PAP) in large-scale trials and recommend protocols to improve adherence.", "results_summary": "Large-scale trials of PAP efficacy were largely negative, primarily due to suboptimal adherence. The study recommends evidence-based adherence protocols to enhance rigor and reproducibility in future trials.", "population_specificity": "Not specified (large-scale trials, general target population implied)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:29.520172+00:00"}
{"study_id": 53539, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of CPAP treatment over 12 months on clinical outcomes for patients with the polysomnography phenotype of REM-related obstructive sleep apnea (REM-OSA).", "results_summary": "CPAP treatment in sleepy patients with moderate to severe REM-OSA was associated with reduced sleepiness (significant decrease in ESS) and improved quality of life (increase in FOSQ), though decreases in DASS-21 and PVT-RT were not sustained. The benefits were primarily seen in the CPAP-adherent subgroup.", "population_specificity": "Patients with subjective sleepiness and diagnostic polysomnography demonstrating moderate to severe REM-OSA.", "effective_dosage": "Average CPAP usage was 2.9 \u00b1 2.4 hours per night.", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:30.611051+00:00"}
{"study_id": 53542, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review behavioral interventions for improving the uptake and maintenance of Continuous Positive Airway Pressure (PAP) treatment and to understand factors contributing to poor adherence.", "results_summary": "The abstract highlights that PAP remains the most effective treatment for obstructive sleep apnea when used properly, but adherence is a significant issue. It reviews studies on behavioral interventions and discusses patient perspectives to address poor uptake and discontinuation.", "population_specificity": "Patients with obstructive sleep apnea (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:34.443484+00:00"}
{"study_id": 53543, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of early initiation of continuous positive airway pressure (CPAP) in preterm infants with respiratory distress syndrome (RDS).", "results_summary": "The study is a randomized controlled trial assessing CPAP in preterm infants (24+0-29+6 weeks corrected GA), but specific efficacy results are not yet published (pre-results).", "population_specificity": "Preterm infants (24+0-29+6 weeks corrected gestational age) with RDS.", "effective_dosage": "CPAP level of 6-8 cmH2O, with titration of fractional inspired oxygen (FiO2).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:36.619966+00:00"}
{"study_id": 53546, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to review the impact of COVID-19 on patients with pituitary disorders, including potential risks related to conditions like sleep-apnea syndrome treated with Continuous Positive Airway Pressure (CPAP).", "results_summary": "The abstract does not provide specific findings on CPAP's effects but highlights that pituitary patients with sleep-apnea syndrome are at higher risk for COVID-19 complications.", "population_specificity": "Patients with pituitary disorders, including those with sleep-apnea syndrome and acromegaly.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:37.365619+00:00"}
{"study_id": 53544, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine the impact of immediate adaptive servo-ventilation (ASV) treatment on infarct progression and clinical outcomes in acute ischemic stroke patients with significant sleep-disordered breathing (SDB).", "results_summary": "The study will assess the feasibility and efficacy of ASV treatment in acute stroke patients with SDB, focusing on infarct progression, clinical outcomes, and physiological parameters, but results are pending as the trial is ongoing.", "population_specificity": "Acute ischemic stroke patients with significant SDB (apnea-hypopnea index >20/h).", "effective_dosage": "Not specified", "study_duration": "Treatment administered from the second night after stroke, with follow-up assessments up to 90 days post-stroke.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:37.995209+00:00"}
{"study_id": 53548, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to compare the impact of nasal intermittent positive pressure ventilation (NIPPV) versus continuous positive airway pressure (CPAP) on apnea of prematurity (AOP) in preterm neonates.", "results_summary": "The study found no difference in AOP frequency per hour between NIPPV and CPAP, but a post hoc analysis showed lower odds of developing any AOP with NIPPV. However, the evidence quality was insufficient for definitive recommendations.", "population_specificity": "Preterm neonates with apnea of prematurity (AOP).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:38.672479+00:00"}
{"study_id": 53547, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the relationship between mask-related side effects (MRSEs) and CPAP non-adherence or residual excessive sleepiness in long-term CPAP-treated patients.", "results_summary": "The study found that leak-related side effects were the most prevalent MRSEs, but patient-reported leaks could not be predicted by CPAP-reported leaks. MRSEs were independently associated with CPAP non-adherence and residual excessive sleepiness, suggesting a need for complementary monitoring approaches.", "population_specificity": "Apneic adults undergoing at least 3 months of CPAP therapy with unrestricted mask access (72.2% male, median age 67 years).", "effective_dosage": "Not specified", "study_duration": "At least 3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:39.327082+00:00"}
{"study_id": 53545, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the association of surgical treatments for OSA with clinically relevant outcomes (cardiovascular, neurological, and endocrine complications) compared to CPAP alone.", "results_summary": "Soft tissue surgery for OSA was associated with lower rates of cardiovascular, neurological, and endocrine complications compared to CPAP alone, while skeletal surgery showed no significant differences. The findings suggest surgery may benefit high-risk CPAP nonadherent patients.", "population_specificity": "Working insured US adults aged 40-89 diagnosed with OSA and prescribed CPAP, with at least 3 years of data.", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 4.47 years (interquartile range, 3-8 years)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:39.556001+00:00"}
{"study_id": 53533, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to assess the feasibility of a large-scale trial and update an economic model to determine the cost-effectiveness and value of further research on prehospital Continuous Positive Airway Pressure (CPAP) compared to standard oxygen therapy for acute respiratory failure.", "results_summary": "The study found that recruitment rates were below target, CPAP was fully delivered to 74% of participants, and 30-day mortality was 27.3%. The economic evaluation suggested uncertainty about CPAP's cost-effectiveness, and limited compliance and difficulty identifying patients who could benefit indicated CPAP was unlikely to significantly reduce mortality.", "population_specificity": "Adults with respiratory distress and peripheral oxygen saturations below British Thoracic Society target levels, excluding those with limited potential to benefit or contraindications to CPAP.", "effective_dosage": "Not specified (CPAP delivered via O-Two system).", "study_duration": "Intervention administered prehospital; follow-up lasted 30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:41.586090+00:00"}
{"study_id": 53549, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the effects of noninvasive positive-pressure ventilation (NPPV) on cardiac function and survival in patients with sleep-disordered breathing and chronic congestive heart failure.", "results_summary": "Short-term ASV treatment (3-6 months) significantly improved event-free survival and cardiac function in HFrEF + CSA patients, but prolonged treatment showed no effect on all-cause mortality and may have negative effects.", "population_specificity": "Heart failure patients with reduced ejection fraction and sleep-disordered breathing (HFrEF + SDB), particularly those with central sleep apnea (CSA).", "effective_dosage": "Not specified", "study_duration": "3-6 months (short-term), prolonged treatment duration not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:43.626468+00:00"}
{"study_id": 53551, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the effect of CPAP treatment on plasma fibrinogen levels in patients with obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis found that long-term CPAP therapy (\u22651 month) with good compliance (\u22654 h/night) significantly reduced plasma fibrinogen levels in OSA patients, while short-term therapy and poor compliance did not show significant effects.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified (compliance measured as \u22654 h/night).", "study_duration": "Long-term (\u22651 month) and short-term (<1 month) subgroups.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:45.444400+00:00"}
{"study_id": 53550, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to evaluate the safety, tolerability, and preliminary efficacy of BIO101 (not Continuous Positive Airway Pressure) in preventing respiratory deterioration in hospitalized COVID-19 patients.", "results_summary": "The abstract does not provide specific results regarding Continuous Positive Airway Pressure, as the study focuses on BIO101.", "population_specificity": "Hospitalized COVID-19 patients aged 45+ with pneumonia and respiratory decompensation.", "effective_dosage": "Not applicable (study focused on BIO101, not CPAP).", "study_duration": "Up to 28 days or until a clinical endpoint was reached.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:45.721854+00:00"}
{"study_id": 53552, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of supplemental oxygen therapy and CPAP on patients with obstructive sleep apnea (OSA).", "results_summary": "CPAP was found to be clinically effective for treating OSA, while supplemental oxygen therapy showed promise in improving nocturnal hypoxia and depression symptoms when CPAP was not tolerated. No significant difference was found in improving nocturnal oxygen saturation between the two treatments.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:45.723369+00:00"}
{"study_id": 53553, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to determine whether changes in ICAM-1 levels following CPAP treatment were associated with improvements in sleepiness and blood pressure in adults with obstructive sleep apnea.", "results_summary": "The study found no significant association between changes in ICAM-1 levels and changes in sleepiness or blood pressure measures after 4 months of CPAP treatment. Future research should explore other potential biomarkers mediating these outcomes.", "population_specificity": "Adults with newly diagnosed obstructive sleep apnea (83% men, mean BMI 31.5 \u00b1 4.2 kg/m\u00b2).", "effective_dosage": "Not specified", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:47.005992+00:00"}
{"study_id": 53555, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the metabolic effects of CPAP versus MAD versus no treatment in patients with mild OSA over 6 and 12 months.", "results_summary": "CPAP was more effective than MAD in reducing total cholesterol and LDL-c over 12 months, despite lower adherence compared to MAD. Both treatments reduced AHI compared to the control group.", "population_specificity": "Patients with mild OSA, aged 18-65, BMI < 35 kg/m\u00b2, 54% male.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:47.792634+00:00"}
{"study_id": 53556, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to examine the association of CPAP use (as a bridge to invasive mechanical ventilation or as a ceiling-of-care) with mortality in COVID-19 patients.", "results_summary": "CPAP showed a favorable therapeutic alternative to early intubation in patients without a ceiling-of-care, with 75% recovering without needing IMV. However, CPAP offered little survival benefit for patients with a ceiling-of-care compared to oxygen therapy alone.", "population_specificity": "Adults with SARS-CoV-2 swab-positive results admitted to Calderdale and Huddersfield NHS Foundation Trust (UK) between March 10 and April 19, 2020.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:49.043337+00:00"}
{"study_id": 53557, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to analyze the characteristics and early risk factors for mortality associated with noninvasive ventilation (NIV), including Continuous Positive Airway Pressure (CPAP), in critically ill children.", "results_summary": "CPAP was used more frequently in younger patients (33.7%) than older ones (9.7%). Risk factors for mortality included immunodeficiency, cerebral palsy, apneas on admission, tachypnea 6 hours after NIV onset, and NIV failure.", "population_specificity": "Critically ill children aged 1 month to 18 years requiring NIV.", "effective_dosage": "Not specified", "study_duration": "Data collected during the first 12 hours of admission; study duration was 2 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:50.513980+00:00"}
{"study_id": 53558, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of Continuous Positive Airway Pressure (CPAP) in improving obstructive sleep apnea (OSA) and reducing seizures in patients with epilepsy.", "results_summary": "CPAP therapy was found to be the most effective non-pharmacological method for improving OSA and reducing seizures in patients with epilepsy. The abstract highlights its efficacy but notes a lack of large-scale randomized controlled trials to further validate these findings.", "population_specificity": "Patients with epilepsy and comorbid sleep disorders, particularly obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:52.077678+00:00"}
{"study_id": 53559, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether treating obstructive sleep apnea (OSA) with continuous positive airway pressure (CPAP) improves depressive symptoms and leads to remission of clinical depression in patients with comorbid OSA and depression.", "results_summary": "CPAP treatment significantly reduced depressive symptoms and sleepiness compared to waitlist controls, and a significant reduction in the proportion of participants meeting criteria for clinical depression was observed in the CPAP group.", "population_specificity": "121 untreated OSA patients with comorbid clinical depression.", "effective_dosage": "Not specified", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:53.266579+00:00"}
{"study_id": 53561, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of CPAP in reducing recurrent vascular events and mortality in poststroke obstructive sleep apnea (OSA) and propose improvements for future trials.", "results_summary": "The study found mixed results regarding CPAP's effectiveness in poststroke OSA, with prior trials being underpowered and inconclusive. It suggests intervention, population, and timing changes to improve future research.", "population_specificity": "Stroke patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified (focus on usage \u22654 hours per night).", "study_duration": "Not specified (proposes early initiation within 48 hours of stroke and long-term follow-up).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:54.847451+00:00"}
{"study_id": 53562, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of CPAP on anxiety in coronary artery disease (CAD) patients with nonsleepy obstructive sleep apnea (OSA) following revascularization.", "results_summary": "CPAP had no significant effect on anxiety scores in the intention-to-treat analysis. However, adherent CPAP users (\u22652.8 h/day) showed a significant increase in anxiety scores after three months and one year, while non-adherent or no-CPAP groups showed a decline.", "population_specificity": "Revascularized CAD patients with nonsleepy OSA (apnea-hypopnea index \u226515/h, Epworth Sleepiness Scale score <10).", "effective_dosage": "Not specified (adherence threshold: \u22652.8 h/day).", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:55.772071+00:00"}
{"study_id": 53563, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to describe the treatments offered to children with severe acute bronchiolitis in a Spanish PICU and analyze changes in management after the 2014 AAP guideline publication.", "results_summary": "Continuous positive airway pressure (CPAP) and bi-level positive airway pressure were used less during 2015-2016 compared to the previous period. Overall, 83% of patients received non-invasive ventilation or high-flow oxygen therapy (HFOT).", "population_specificity": "Children admitted to a Spanish tertiary pediatric intensive care unit (PICU) with severe acute bronchiolitis (median age 1.8 months).", "effective_dosage": "Not specified", "study_duration": "Two epidemic waves (2014-2015 and 2015-2016)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:56.244245+00:00"}
{"study_id": 53564, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the role of hypoglossal nerve stimulation (HNS) as an alternative treatment for CPAP-intolerant obstructive sleep apnea (OSA) patients and discuss post-implant management strategies.", "results_summary": "The study highlights HNS as a well-established, effective alternative for CPAP-intolerant OSA patients, with robust safety, efficacy, and durability data from multiple trials and registries. However, it emphasizes the need for standardized post-implant management to optimize long-term outcomes, particularly for patients with partial responses.", "population_specificity": "CPAP-intolerant obstructive sleep apnea (OSA) patients.", "effective_dosage": "Not mentioned", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:57.104640+00:00"}
{"study_id": 53565, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of Continuous Positive Airway Pressure (CPAP) as a sleep intervention for individuals with Mild Cognitive Impairment (MCI) or mild Alzheimer's Disease (AD) dementia, particularly those with Obstructive Sleep Apnoea.", "results_summary": "CPAP demonstrated efficacy in participants with Obstructive Sleep Apnoea, though the abstract does not specify the magnitude of improvement. The study highlights a lack of extensive evidence for other sleep interventions in this population.", "population_specificity": "Individuals with Mild Cognitive Impairment (MCI) or mild Alzheimer's Disease (AD) dementia, particularly those with Obstructive Sleep Apnoea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:59.071861+00:00"}
{"study_id": 53566, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of Helmet CPAP versus HFNC in reducing the need for invasive mechanical ventilation in COVID-19 patients with hypoxaemia.", "results_summary": "The study hypothesizes that Helmet CPAP may reduce the need for intubation compared to HFNC, but direct comparative results are pending as the trial was planned and not yet completed at the time of the abstract.", "population_specificity": "COVID-19 patients with hypoxaemia despite conventional low-flow oxygen therapy, treated at an intermediate-level COVID-19 cohort ward in Helsingborg Hospital, Sweden.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:59.589584+00:00"}
{"study_id": 53567, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate pressure stability and imposed work of breathing (iWOB) of five CPAP systems used in low-resource settings to treat respiratory distress in neonates.", "results_summary": "The study found significant differences in resistance and iWOB among the five CPAP systems, with three devices showing lower resistance (<0.4) and two showing higher resistance (>1.0). The available literature does not indicate these differences affect clinical outcomes.", "population_specificity": "Preterm and term neonates (simulated infant sizes: 2.5 kg, 4.0 kg, 5.5 kg).", "effective_dosage": "Pressures generated at the bottle: 0, 3, 5, and 7 cm H2O.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:02.085292+00:00"}
{"study_id": 53568, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether sustained lung inflation (SLI) followed by nasal CPAP reduces the need for invasive mechanical ventilation (IMV) in preterm infants compared to nasal CPAP alone.", "results_summary": "SLI did not significantly reduce the need for IMV in the overall study population but showed efficacy in subgroups of sicker infants (those with clinical eligibility criteria) and smaller babies (gestational age <30 weeks). The study concluded that SLI was not harmful.", "population_specificity": "Preterm infants with gestational age \u226527 and \u226432 weeks.", "effective_dosage": "SLI at 20 cmH2O for 15 seconds followed by nasal CPAP at 5 cmH2O.", "study_duration": "First 72 hours of life.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:02.521087+00:00"}
{"study_id": 53569, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine regional ventilation characteristics during non-invasive ventilation (NIV) in stable preterm infants and explore the relationship between ventilation homogeneity and respiratory status indicators.", "results_summary": "Ventilation was greater in the right lung (mean 69.1%) and favored the non-dependent lung, with ventilation inhomogeneity associated with worse oxygenation. High breath-by-breath variability in regional ventilation patterns was observed during NIV.", "population_specificity": "Forty stable preterm infants born <30 weeks of gestation receiving either continuous positive airway pressure (n=32) or high-flow nasal cannulae (n=8).", "effective_dosage": "Clinician-determined non-invasive settings.", "study_duration": "60 minutes of quiet breathing.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:03.789869+00:00"}
{"study_id": 53571, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the long-term effect of CPAP on blood pressure in patients with obstructive sleep apnea (OSA) and resistant hypertension.", "results_summary": "Good adherence to long-term CPAP treatment significantly reduced 24-hour blood pressure, particularly during the night, and decreased the need for antihypertensive medications. A positive correlation was found between CPAP use duration and systolic blood pressure reduction.", "population_specificity": "Patients diagnosed with both OSA (AHI \u226515) and resistant hypertension.", "effective_dosage": "CPAP use of at least 4 hours per night (defined as good adherence).", "study_duration": "Follow-up within 59 months (IQR: 44-70).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:05.661684+00:00"}
{"study_id": 53572, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to describe the use and efficacy of alternative CPAP devices in COVID-19 patients with respiratory failure.", "results_summary": "Alternative CPAP improved oxygenation parameters in patients, with a progressive increase in saturation (94% to 98-99%) and a statistically significant improvement in oxygen saturation/inspired oxygen fraction (p = 0.040). However, changes in respiratory frequency were not significant (p = 0.423).", "population_specificity": "23 COVID-19 patients with respiratory failure admitted to IFEMA Field Hospital.", "effective_dosage": "Not specified", "study_duration": "Measurements taken at 30 and 60 minutes after mask application.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:05.727561+00:00"}
{"study_id": 53573, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to validate the Saturation Oxygen Pressure Index (SOPI) as a non-invasive tool for monitoring respiratory distress in neonates on CPAP and determine its correlation with A-aDO2.", "results_summary": "The study found a significant positive correlation (82.7%) between SOPI and A-aDO2, with SOPI values of 1.52, 1.57, and 1.6 predicting A-aDO2 values of 70, 85, and 100, respectively, with high sensitivity and specificity.", "population_specificity": "126 neonates with respiratory distress treated with CPAP.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:08.094087+00:00"}
{"study_id": 53574, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and safety of high-flow nasal cannula (HFNC) against nasal continuous positive airway pressure (NCPAP) or nasal intermittent positive-pressure ventilation (NIPPV) after extubation in preterm infants.", "results_summary": "The study found that HFNC had a significantly higher rate of treatment failure (31%) compared to NCPAP/NIPPV (16%). Factors associated with HFNC failure included histologic chorioamnionitis, treated patent ductus arteriosus, and younger corrected gestational age.", "population_specificity": "Preterm infants born at <34 weeks who needed noninvasive ventilation after extubation.", "effective_dosage": "Not specified", "study_duration": "7 days after extubation", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:08.428201+00:00"}
{"study_id": 53577, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the potential therapeutic role of adjuvant Hemoperfusion (HP) in COVID-19 patients with severe pneumonia requiring continuous positive airway pressure.", "results_summary": "The study found that patients treated with HP showed better clinical outcomes, including higher survival rates and reduced need for intubation, compared to controls. Respiratory function remained stable in treated patients, and inflammatory markers decreased more significantly in the HP group.", "population_specificity": "9 consecutive patients hospitalized in a COVID Intensive Care Unit with severe pneumonia requiring continuous positive airway pressure.", "effective_dosage": "2 consecutive sessions of HP using CytoSorb cartridge.", "study_duration": "HP was started 6-7 days after hospital admission.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:11.174607+00:00"}
{"study_id": 53576, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To evaluate the effects of CPAP therapy on corneal endothelial morphometry and pachymetry in patients with obstructive sleep apnea-hypopnea syndrome (OSAHS).", "results_summary": "CPAP treatment improved corneal polymegathism (reduced CV) and pleomorphism (increased %Hex), with post-CPAP values resembling those of healthy controls. Greater improvement in polymegathism correlated with longer treatment duration and higher pre-CPAP NREM sleep percentage.", "population_specificity": "27 patients recently diagnosed with OSAHS (mean age 54.2 \u00b1 11.8 years).", "effective_dosage": "Not specified", "study_duration": "9.6 months (range 3-18 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:11.255948+00:00"}
{"study_id": 53578, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to describe the clinical course, treatment, and outcomes of COVID-19 pneumonia patients, with a focus on oxygen delivery and ventilator support, including CPAP/NIV.", "results_summary": "CPAP/NIV showed mixed outcomes: high mortality (88.9%) in DNI patients, 57.1% NIV failure in non-DNI patients, but 96.3% survival in those who did not require mechanical ventilation.", "population_specificity": "310 consecutive COVID-19 pneumonia patients admitted to an emergency room in Lombardy, Italy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:12.306605+00:00"}
{"study_id": 53579, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of early surfactant administration on CPAP failure rates and clinical outcomes in very preterm infants with respiratory distress syndrome.", "results_summary": "Early surfactant administration reduced CPAP failure rates, with 100% of infants in the surfactant group receiving surfactant compared to 49% in the control group, and was associated with lower morbidity and mortality.", "population_specificity": "Very preterm infants (<32 weeks) with respiratory distress syndrome, initially managed on CPAP.", "effective_dosage": "Not specified", "study_duration": "First 5 days of life", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:13.459975+00:00"}
{"study_id": 53580, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize key aspects of bilevel PAP therapies, including CPAP, for treating sleep-related breathing disorders and central sleep apnea syndromes.", "results_summary": "The abstract highlights that CPAP and bilevel PAP therapies were developed to address obstructive sleep apnea and complex sleep-related breathing disorders, with advanced modes of NIV addressing broader cardiorespiratory pathophysiology.", "population_specificity": "Patients with obstructive sleep apnea, sleep-related hypoventilation disorders, treatment-emergent central sleep apnea, and central sleep apnea syndromes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:14.070119+00:00"}
{"study_id": 53570, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate predictors of 28-day mortality in COVID-19 patients, including the impact of Continuous Positive Airway Pressure (CPAP) treatment.", "results_summary": "The study found that the need for CPAP/NIV within the first 24 hours was a significant risk factor for 28-day mortality (OR 8.38). CPAP was used in 39% of patients, but its efficacy was not directly compared to other treatments.", "population_specificity": "COVID-19 patients admitted to the main hospital of Bergamo, Italy, during the peak of the outbreak (February 23 to March 14, 2020), predominantly male (72.4%) with a mean age of 66\u00b115 years.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:15.914669+00:00"}
{"study_id": 53581, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of CPAP versus MAD in treating severe OSA patients with mandibular retrognathia.", "results_summary": "CPAP was superior to MAD in improving polysomnographic outcomes and Snore Scale scores, but MAD had higher compliance. Both treatments showed similar effectiveness in ESS and SAS scores. MAD was more effective in OSA patients with mandibular retrognathia than those without.", "population_specificity": "Severe OSA patients with mandibular retrognathia (ANB > 4.7\u00b0 and SNB < 76.2\u00b0).", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:16.368331+00:00"}
{"study_id": 53582, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of CPAP treatment on glycaemic control and insulin resistance in patients with type 2 diabetes and obstructive sleep apnoea.", "results_summary": "CPAP significantly improved glycaemic control and insulin resistance, as evidenced by reduced HbA1c levels, fasting glucose levels, and HOMA-IR values, along with lowered systolic and diastolic blood pressure.", "population_specificity": "Patients with type 2 diabetes and obstructive sleep apnoea (691 participants across 7 trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:16.927139+00:00"}
{"study_id": 53583, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "To compare immediate cessation versus stepwise pressure reduction of NCPAP on therapy duration in preterm infants.", "results_summary": "No difference in total NCPAP days between groups, but gradual weaning reduced failure rates at first discontinuation attempt, especially in infants 23-27 weeks gestational age.", "population_specificity": "Preterm infants (23-30 weeks gestational age).", "effective_dosage": "Stepwise pressure wean to 3 cm H2O.", "study_duration": "Median 14-16 days (interquartile range 5-36 days).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:19.423095+00:00"}
{"study_id": 53584, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether depression, anxiety, and stress symptoms before treatment affect the effectiveness of cognitive behavioral therapy for insomnia (CBTi) in patients with comorbid insomnia and sleep apnea (COMISA).", "results_summary": "The study found that CBTi improved insomnia symptoms in patients with COMISA, regardless of the severity of depression, anxiety, or stress symptoms before treatment. No evidence suggested that these comorbid symptoms impaired CBTi's effectiveness.", "population_specificity": "145 patients with comorbid insomnia and sleep apnea (insomnia per ICSD-3 criteria and AHI \u2265 15 events/h).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:20.095871+00:00"}
{"study_id": 53585, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether CPAP treatment reduces the incidence of reflux events in patients with obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis found that CPAP treatment significantly reduced reflux events, with notable improvements in percentage time pH < 4, longest reflux duration, number of reflux events, DeMeester score, RDQ score, and RSI. Subgroup analysis indicated greater symptom improvement with longer treatment duration.", "population_specificity": "Patients with obstructive sleep apnea (OSA) and gastroesophageal reflux disease (GERD).", "effective_dosage": "Not specified", "study_duration": "Not specified (subgroup analysis suggests longer durations yield better results)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:21.587655+00:00"}
{"study_id": 53587, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate how upper airway anatomy influences CPAP titration levels in patients with obstructive sleep apnea (OSA).", "results_summary": "The study found significant correlations between CPAP titration levels and upper airway length, distance from mandibular plane to hyoid bone, and neck circumference. BMI and upper airway length were independently associated with CPAP titration levels, suggesting these factors should be considered for improving CPAP compliance.", "population_specificity": "157 subjects (134 males, 23 females) under investigation for OSA via polysomnography and CT scan.", "effective_dosage": "Not specified", "study_duration": "Full-night manual titration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:22.657506+00:00"}
{"study_id": 53586, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether adding intranasal steroids (fluticasone furoate) to CPAP therapy reduces nasal symptoms and improves compliance in patients with obstructive sleep apnea (OSA).", "results_summary": "The study found that intranasal steroids significantly improved CPAP compliance and reduced rhinorrhea and congestion symptoms after 90 days, though no difference was observed at 30 days.", "population_specificity": "83 patients with obstructive sleep apnea (OSA) receiving CPAP therapy.", "effective_dosage": "Fluticasone furoate nasal spray 55 \u03bcg (frequency not specified).", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:23.350377+00:00"}
{"study_id": 53588, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of CPAP on markers of arterial stiffness (PWV and Aix) in patients with obstructive sleep apnea (OSA).", "results_summary": "CPAP significantly improved arterial stiffness by reducing pulse wave velocity (PWV) but did not significantly affect augmentation index (Aix). The analysis included 9 randomized trials with moderate risk of bias.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:23.427283+00:00"}
{"study_id": 53589, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the acute and long-term effects of neonatal exposure to Continuous Positive Airway Pressure (CPAP) on lung structure and function using animal models.", "results_summary": "CPAP improves lung function, causes less lung injury compared to mechanical ventilation, and does not disrupt alveolar development. However, CPAP may increase airway reactivity, and combining it with surfactant administration further enhances respiratory outcomes.", "population_specificity": "Newborn animal models (large and small animals).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:24.552094+00:00"}
{"study_id": 53590, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the role of high-flow nasal cannula (HFNC) in COVID-19 patients after failure of Continuous Positive Airway Pressure (CPAP) or non-invasive mechanical ventilation (NIV).", "results_summary": "The study found that CPAP or NIV were uncomfortable and required significant man-machine cooperation, leading to failure in some patients. HFNC was successfully used in selected COVID-19 patients with ARDS after CPAP/NIV failure.", "population_specificity": "Five patients with COVID-19-related ARDS.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:25.126171+00:00"}
{"study_id": 53591, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the relationship between obstructive sleep apnea (OSA) and arterial stiffness, focusing on the cardio-ankle vascular index (CAVI), and how CPAP treatment affects CAVI.", "results_summary": "The study found that CPAP treatment for OSA can reduce the CAVI, indicating a potential reduction in arterial stiffness and atherosclerosis risk. Several studies support CPAP's effectiveness in improving arterial health in OSA patients.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:27.185716+00:00"}
{"study_id": 53592, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the procedural and clinical outcomes of introducing minimally invasive surfactant therapy (MIST) in neonatal intensive care units.", "results_summary": "MIST was successfully introduced in neonatal units with limited prior experience, and premedication with atropine reduced bradycardia incidence. Success rates improved when performed by clinicians skilled in endotracheal intubation.", "population_specificity": "Preterm infants in two tertiary Australian neonatal intensive care units (median gestation 30 weeks).", "effective_dosage": "Not specified", "study_duration": "Data collected over 18 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:27.919493+00:00"}
{"study_id": 53593, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of CPAP on the need for intermittent positive pressure ventilation (IPPV) and associated morbidity in preterm infants with respiratory distress.", "results_summary": "CPAP reduced the risk of treatment failure (death or use of assisted ventilation) but was associated with an increased rate of pneumothorax compared to spontaneous breathing with supplemental oxygen. The applicability of results to current practice is unclear due to the age of most trials.", "population_specificity": "Preterm infants with respiratory distress.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:29.880976+00:00"}
{"study_id": 53594, "supplement_id": 1048, "safety_score": "65", "efficacy_score": 40, "quality_score": 30, "study_goal": "To determine if early initiation of CPAP reduces mortality and the need for intermittent positive-pressure ventilation in preterm infants with respiratory distress.", "results_summary": "The study found very low-certainty evidence on whether early CPAP affects the need for ventilation or mortality, with uncertain effects on air leak (pneumothorax). No significant adverse effects were reported, but long-term outcomes were not assessed.", "population_specificity": "Preterm infants in respiratory distress.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:30.580672+00:00"}
{"study_id": 53596, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 65, "study_goal": "The researchers aimed to assess the characteristics of COVID-19 patients diagnosed with pulmonary embolism (PE), including the use of Continuous Positive Airway Pressure (CPAP) in their treatment.", "results_summary": "Among 15 COVID-19 patients with PE, 47% required CPAP, with 13% of those subsequently requiring intubation. The study did not focus on CPAP's efficacy but noted its use in severe cases.", "population_specificity": "COVID-19 patients admitted between March and April 2020, diagnosed with PE (median age 58, 87% male).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:32.022531+00:00"}
{"study_id": 53595, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess the feasibility and outcomes of using Continuous Positive Airway Pressure (CPAP) in a non-ICU setting for patients with acute respiratory failure during a COVID-19 surge.", "results_summary": "CPAP was initiated in 49 patients, with 38% recovering without intubation. Intubation was required in 51% of cases, while poor tolerance or death occurred in 16%.", "population_specificity": "Hypoxemic patients with respiratory failure or inability to maintain SpO2 > 90% despite high-flow oxygen, predominantly male (73%) with a median age of 65.", "effective_dosage": "Not specified (CPAP settings not detailed).", "study_duration": "Median duration of CPAP was 3 days (IQR = 1-5).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:33.467165+00:00"}
{"study_id": 53598, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the relationship between the severity of hypoxic acute respiratory failure (hARF) and clinical outcomes, including the use of continuous positive airway pressure (CPAP), in hospitalized COVID-19 patients.", "results_summary": "The study found that the severity of hARF, as measured by PaO2/FiO2 ratio, was independently associated with a threefold increase in in-hospital mortality. CPAP was used as part of the treatment, but its specific efficacy was not detailed beyond its inclusion in secondary outcomes.", "population_specificity": "Hospitalized adult patients with virologically confirmed COVID-19 in three academic hospitals in Milan, Italy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:34.704025+00:00"}
{"study_id": 53597, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Continuous Positive Airway Pressure (CPAP) mitigates ventilator-induced lung injury in severe acute respiratory distress syndrome (ARDS) patients on venovenous extracorporeal membrane oxygenation (VV-ECMO), compared to pressure-controlled ventilation.", "results_summary": "The study found a linear relationship between driving pressure changes and plasma biomarkers of lung injury, suggesting that reducing driving pressure to zero (via CPAP) may offer more protective ventilation for ARDS patients on VV-ECMO, though clinical outcomes require further validation.", "population_specificity": "Ten patients with severe ARDS supported on VV-ECMO.", "effective_dosage": "Continuous Positive Airway Pressure (specific pressure not detailed) administered for 2 hours.", "study_duration": "2 hours per phase (CPAP phase).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:34.883174+00:00"}
{"study_id": 53599, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of CPAP treatment on cognitive trajectory and Alzheimer's disease biomarkers in patients with obstructive sleep apnea (OSA).", "results_summary": "The review found that CPAP treatment may influence Alzheimer's disease biomarkers and cognitive outcomes in OSA patients, though further studies are needed to confirm these effects and establish preventive strategies for Alzheimer's disease.", "population_specificity": "Elderly and adult patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:35.033733+00:00"}
{"study_id": 53600, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to summarize the definition, epidemiology, mechanisms, clinical characteristics, and treatment of Treatment-emergent central sleep apnea (TECSA) during Continuous Positive Airway Pressure (CPAP) therapy.", "results_summary": "TECSA may resolve spontaneously with ongoing CPAP treatment in some patients, but persists in others, requiring alternative therapies like adaptive servo-ventilation. The prevalence and mechanisms of TECSA vary widely, indicating a need for further research.", "population_specificity": "Patients with Treatment-emergent central sleep apnea (TECSA) during CPAP therapy for obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:36.752216+00:00"}
{"study_id": 53602, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether CPAP treatment reduces daytime resting heart rate in individuals with OSA and prediabetes.", "results_summary": "CPAP treatment reduced daytime resting heart rate by 4.1 beats/min compared to placebo, with statistically significant results. The study suggests CPAP may have cardiovascular benefits in this population.", "population_specificity": "39 participants with obstructive sleep apnea (OSA) and prediabetes.", "effective_dosage": "In-laboratory all-night CPAP (optimal CPAP).", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:38.163417+00:00"}
{"study_id": 53601, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to compare two different PEEP levels (6-8 cmH2O vs. 4-6 cmH2O) during nasal CPAP treatment in preterm infants to determine the optimal level for treating respiratory distress syndrome.", "results_summary": "The abstract does not provide specific results but indicates that the optimum PEEP level for treating respiratory distress syndrome in preterm infants is unknown, as previous trials used a wide range of PEEP levels (4-8 cmH2O). The study is designed to address this gap.", "population_specificity": "Preterm infants born at 26+0-29+6 gestational weeks.", "effective_dosage": "Two PEEP levels: 6-8 cmH2O and 4-6 cmH2O.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:39.798617+00:00"}
{"study_id": 53603, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of supraglottic airway devices for surfactant delivery as an alternative to CPAP or endotracheal tube administration in infants with respiratory distress syndrome.", "results_summary": "The study found that surfactant administration via supraglottic airway devices had a high success rate and may reduce the need for subsequent intubation compared to CPAP or endotracheal tube delivery, though existing RCTs are limited in sample size and heterogeneity.", "population_specificity": "Infants with respiratory distress syndrome, primarily in tertiary care settings.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:40.695455+00:00"}
{"study_id": 53604, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether continuous positive airway pressure (CPAP) therapy improves erectile dysfunction (ED) symptoms in patients with obstructive sleep apnoea (OSA).", "results_summary": "The study found that CPAP therapy significantly improved ED symptoms in OSA patients based on IIEF-5 scores, though heterogeneity among studies and limited sample size warrant further research.", "population_specificity": "206 male patients with erectile dysfunction and obstructive sleep apnoea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:41.479397+00:00"}
{"study_id": 53607, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to describe real-life ASV settings and associated minute-ventilations for different ASV devices, and assess hyperventilation risks in patients with sleep-disordered breathing.", "results_summary": "The study found that real-life ASV settings are influenced by baseline and follow-up variables, with cardiological factors remaining clinically significant. It highlighted a hyperventilation risk across patient clusters, suggesting potential benefits of MV-telemonitoring for safety.", "population_specificity": "Patients on ASV treatment for at least 1 year, primarily male (87.57%), with conditions like OSA, CSA, or TECSA.", "effective_dosage": "Not specified", "study_duration": "6 months of ASV data collection", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:44.071332+00:00"}
{"study_id": 53605, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine changes in catecholamine levels and blood pressure in response to CPAP treatment in patients with obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis found conflicting impacts of CPAP treatment on catecholamine levels and blood pressure, with results from 38 studies (14 RCTs and 24 PCS) analyzed. The study used standardized mean difference (SMD) for catecholamines and mean difference (MD) for systolic and diastolic blood pressure.", "population_specificity": "Patients with obstructive sleep apnea (OSA), mean age 41-62 years, BMI 27.2-35.1 kg/m\u00b2.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:44.506579+00:00"}
{"study_id": 53606, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of CPAP, a mandibular advancement device (MAD), and no treatment on blood pressure and endothelial function in individuals with mild obstructive sleep apnea over 6 and 12 months.", "results_summary": "CPAP and MAD reduced apnea-hypopnea indexes compared to no treatment, but neither improved blood pressure or endothelial function after 1 year, even in patients with effective treatment adherence. CPAP showed higher blood oxygen levels than MAD, but MAD had better treatment adherence and adaptation rates.", "population_specificity": "Individuals aged 18-65 with mild obstructive sleep apnea (AHI < 5 events/h) and BMI \u2264 35 kg/m\u00b2.", "effective_dosage": "CPAP: 3.8 \u00b1 3.4 hours/night; MAD: 5.7 \u00b1 2.7 hours/night.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:45.144628+00:00"}
{"study_id": 53609, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether CPAP treatment improves moderate to vigorous physical activity levels in individuals with obstructive sleep apnea and co-occurring cardiovascular disease.", "results_summary": "The CPAP group reported significantly more physical activity (20% higher moderate activities), less limitation in physical activity, and more participants meeting recommended activity levels compared to the usual care group.", "population_specificity": "Individuals aged 45-75 with confirmed cardiovascular disease and obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Mean follow-up of 3.7 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:45.756324+00:00"}
{"study_id": 53608, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers compared the effectiveness of upper airway stimulation (UAS) to continuous positive airway pressure (CPAP) for treating moderate to severe obstructive sleep apnea (OSA) in patients who failed CPAP therapy.", "results_summary": "The study found that UAS showed favorable success rates and low morbidity compared to traditional surgical treatments for OSA, though concerns remain about narrow candidacy criteria and long-term durability. CPAP was not directly evaluated in this study, but UAS was presented as an alternative for CPAP-resistant cases.", "population_specificity": "Patients with moderate to severe OSA who failed CPAP therapy, particularly those with lymphoid and muscular tongue base hypertrophy.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:45.960824+00:00"}
{"study_id": 53610, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of two oral appliance designs in reducing the respiratory event index (REI) in moderate and severe OSA patients who were dissatisfied with CPAP therapy.", "results_summary": "The abstract does not provide specific results regarding CPAP's effects, only noting that patients were dissatisfied with it. The study focused on comparing two OA designs rather than evaluating CPAP directly.", "population_specificity": "Moderate and severe adult OSA patients previously prescribed CPAP but dissatisfied with it.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:47.697727+00:00"}
{"study_id": 53611, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether adding a weight-loss Mediterranean diet/lifestyle intervention to standard CPAP treatment improves obstructive sleep apnea (OSA) severity more than CPAP alone.", "results_summary": "The study found that combining CPAP with a Mediterranean diet/lifestyle intervention led to significantly greater reductions in OSA severity and symptoms compared to CPAP alone, with benefits independent of weight loss. The Mediterranean lifestyle group also showed improved sleep quality and reduced daytime sleepiness compared to the diet-only group.", "population_specificity": "Overweight adults (men and women) diagnosed with moderate-to-severe OSA (AHI \u2265 15 events/h).", "effective_dosage": "Not specified (CPAP settings not detailed in the abstract).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:51.382955+00:00"}
{"study_id": 53613, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to assess the association between Continuous Positive Airway Pressure (CPAP) and in-hospital mortality in COVID-19 patients with pneumonia.", "results_summary": "The study found that mechanical ventilation/CPAP was directly associated with increased in-hospital mortality (HR 2.726, 95% CI 1.823-4.074, P < 0.001), suggesting a negative outcome for CPAP use in this context. However, the study primarily focused on HCQ + azithromycin treatment effects, not CPAP's standalone efficacy.", "population_specificity": "377 consecutive patients admitted for COVID-19-related pneumonia (mean age 71.8 \u00b1 13.4 years, 34.2% women).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:51.514671+00:00"}
{"study_id": 53614, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to identify risk factors for non-invasive/invasive ventilatory support (including CPAP) in COVID-19 patients.", "results_summary": "The study found that 31.5% of patients required CPAP, and independent risk factors for ventilatory support included elevated temperature, LDH, and d-dimer levels. CPAP was part of the oxygen therapy strategies but was not directly evaluated for efficacy or safety.", "population_specificity": "COVID-19 patients admitted to the Infectious Diseases Unit and ICU of Santa Maria Annunziata Hospital (Florence, Italy).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:52.999805+00:00"}
{"study_id": 53616, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a telemonitoring system could improve CPAP therapy adherence among Asian patients with moderate-to-severe obstructive sleep apnea (OSA).", "results_summary": "The telemonitoring group showed a non-significant trend toward higher CPAP usage hours, significantly better adherence rates, lower leakage, and improved sleep quality compared to usual care, though adverse events and daytime sleepiness reduction were similar between groups.", "population_specificity": "Asian adults (70% male) with moderate-to-severe OSA.", "effective_dosage": "Not specified (CPAP usage measured in hours/night).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:53.563725+00:00"}
{"study_id": 53615, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine whether combination therapy (CPAP + OA) reduces therapeutic CPAP requirements in patients with an incomplete response to oral appliance therapy alone.", "results_summary": "The study recruited 16 incomplete responders to OA therapy (residual AHI > 10 events/h) to evaluate the effects of combining CPAP with a novel oral appliance. The abstract does not provide specific results on the extent of CPAP requirement reduction.", "population_specificity": "16 incomplete responders to OA therapy (3 women, 13 men, aged 31-65 yr, BMI: 22-38 kg/m\u00b2).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:53.989533+00:00"}
{"study_id": 53618, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the impact of CPAP therapy on Alzheimer's disease biomarkers, cognitive function, and neurophysiology in individuals with obstructive sleep apnea (OSA).", "results_summary": "CPAP therapy shows potential in normalizing Alzheimer's disease biomarkers (e.g., amyloid-\u03b2 and tau) in cerebrospinal fluid and improving cognitive domains like attention, particularly in middle-aged adults with severe OSA. However, evidence remains preliminary, and large longitudinal studies are lacking.", "population_specificity": "Individuals with obstructive sleep apnea (OSA), including younger and older adults, with varying severity of OSA and cognitive impairment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:55.308102+00:00"}
{"study_id": 53619, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to assess whether Continuous Positive Airway Pressure (CPAP) treatment reduces visceral adipose tissue (VAT) in patients with obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis found no significant reduction in VAT after CPAP treatment in OSA patients, with subgroup analyses confirming no influence from therapy duration, age, sample size, or baseline BMI.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified (subgroup analysis considered duration but exact lengths not detailed)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:55.361235+00:00"}
{"study_id": 53617, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of bubble continuous positive airway pressure (bCPAP) versus nasal oxygen in treating respiratory distress in neonates, measured by the Silverman Anderson Retraction Score (SARS).", "results_summary": "bCPAP was significantly more effective than nasal oxygen, with 93.3% effectiveness in the bCPAP group compared to 71.7% in the control group (p = 0.003). The median reduction in SARS was also greater in the bCPAP group (4 vs. 3, p < 0.001).", "population_specificity": "Neonates with respiratory distress admitted to the Department of Paediatrics, Unit-1, KEMU/Mayo Hospital, Lahore, Pakistan.", "effective_dosage": "Not specified", "study_duration": "48 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:55.908955+00:00"}
{"study_id": 53620, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess the effect of CPAP therapy on MDA levels in patients with OSA using meta-analysis to resolve inconsistencies in previous findings.", "results_summary": "Pooled analysis showed CPAP therapy significantly reduced MDA levels, with subgroup analyses confirming effectiveness across age and BMI categories. The study concluded CPAP has a considerable effect on MDA, a marker linked to cardiovascular risk.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:59.372288+00:00"}
{"study_id": 53622, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to analyze the association between risk-seeking behavior in the health/safety domain and CPAP discontinuation among OSA patients.", "results_summary": "The study found that risk-seeking patients were more likely to discontinue CPAP, and those with an AHI <30 also showed higher discontinuation rates. The DOSPERT scale was identified as a useful tool for screening such patients.", "population_specificity": "Consecutive OSA patients prescribed CPAP in a multicenter cohort.", "effective_dosage": "Not specified", "study_duration": "At least 6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:00.781116+00:00"}
